Natural orifice surgery system

Information

  • Patent Grant
  • 10952768
  • Patent Number
    10,952,768
  • Date Filed
    Thursday, November 29, 2018
    6 years ago
  • Date Issued
    Tuesday, March 23, 2021
    3 years ago
Abstract
Embodiments of a surgical access port system that comprises a retractor that is adapted for being coupled to a cap and that is particularly useful in natural orifice surgery are described. The retractor comprises an outer ring, wherein the outer ring is configured to be disposed proximate the natural orifice of the patient and substantially surround the orifice; a tubular body; and various stabilizing mechanisms surrounding the tubular body, sized and configured to stabilize and retain the retractor within the orifice. The stabilizing embodiments described herein are useful in all natural orifices and are of particular use in the vaginal surgery.
Description
BACKGROUND
Technical Field

This application is generally directed to surgical devices, and more particularly, to an access device adapted for use with a cap, that is useful in natural orifice single-port surgical procedures and which is particularly useful in vaginal surgical procedures.


Description of the Related Art

Access devices are commonly used in surgery to facilitate the introduction of various surgical instruments into natural biological vessels, conduits, orifices, cavities, and other interior regions of the body. These access devices include, for example, devices that facilitate the introduction of a needle into a vessel, and trocars that facilitate the introduction of laparoscopic instruments into the abdomen of the body.


Some of these access devices are introduced into regions that include a fluid or gas under pressure. In the case of a needle access device, the pressure may be from a liquid, such as blood. In the case of a trocar, the pressure may be from a gas, such as an insufflation gas. In either case, it is desirable to provide for the introduction of the surgical instrument into the cavity without permitting the escape of the pressurized fluid or gas.


In the case of trocars, a cannula at the distal end of the trocar is typically connected to a seal housing at the proximal end of the trocar. Together the cannula and housing form a working channel through which various instruments can be inserted to access the cavity. Seal mechanisms are commonly disposed in the housing and include a septum valve that seals the working channel when an instrument is in place, and a zero closure valve that seals the working channel when the instrument is removed.


Current surgical access ports allow for single instrument access through each port, or allow for multiple instrument access through a rigid cannula. Some devices, such as transanal endoscopic microsurgery (TEMS) units require that the device be attached to the surgical table to support the weight of the device, as well as to locate the position of the device respective to the patient. These devices do not provide flexibility to the surgeon in selecting instrument size, and they restrict instrument movement with their rigid cannulas. Additionally, surgeons are performing laparoscopic surgical procedures through a single or a limited number of access ports. The procedures may be performed through a single two (2) centimeter incision at the umbilicus, or in certain cases, trans-vaginally or trans-anally. What is needed is a system that meets the needs of these new procedures, facilitating more flexible movement of laparoscopic instruments through a single or limited number of ports while preventing the escape of pressured fluids or gasses and permitting large specimen removal. What is particularly needed is an access system that can be deployed into a natural body cavity, such as the vagina, providing a sealed system for insufflation and a platform for the introduction of multiple surgical instruments of varying sizes, while maintaining sufficient stability for anchoring the system within the cavity without damaging the body cavity wall.


SUMMARY OF THE INVENTION

The invention is directed to a surgical access port system adapted for performing surgical procedures at a natural orifice comprising, an outer ring, wherein the outer ring is configured to be disposed proximate the natural orifice of the patient; a tubular body having a longitudinal axis, a proximal end and a distal end; a funnel segment extending between and coupling the outer ring and the proximal end of the tubular body, wherein the funnel segment provides a diametric reduction between the outer ring and the tubular body; and a flange disposed around the tubular body, the flange comprising a circular ridge circumscribing a channel, wherein the flange is adapted to secure the retractor within the body orifice. The flange may be disposed around the distal or the proximal end of the tubular body.


Optionally, the surgical access port system further comprises a removable gel cap, wherein the gel cap comprises a gel pad and a cap ring coupled with the gel pad, wherein the cap ring is engagable with the outer ring.


In another embodiment, the surgical access port system comprises an outer ring, wherein the outer ring is configured to be disposed proximate the natural orifice of the patient; a tubular body having a longitudinal axis, a proximal end and a distal end; a funnel segment extending between and coupling the outer ring and the proximal end of the tubular body, wherein the funnel segment provides a diametric reduction between the outer ring and the tubular body; and a frustoconical bolster disposed around the tubular body, the bolster comprising a first diameter at a distal end and a second diameter at a proximal end, the second diameter being larger than the first diameter, wherein the bolster is adapted to externally occlude the natural orifice.


In some embodiments, the bolster comprises at least one of a thermoset polymer and a thermoplastic elastomer. In some embodiments, the bolster is fixed around the proximal end of the tubular body. Optionally, the access system further comprises a flange disposed around the tubular body, distal to the bolster and/or an inflatable balloon disposed around the tubular body, distal to the bolster. In some embodiments, the bolster is slidably engaged with the tubular body.


In another embodiment, the surgical access port system comprises an outer ring, wherein the outer ring is configured to be disposed proximate the natural orifice of the patient; a tubular body having a longitudinal axis, a proximal end and a distal end; a funnel segment extending between and coupling the outer ring and the proximal end of the tubular body, wherein the funnel segment provides a diametric reduction between the outer ring and the tubular body; a mechanical balloon disposed around the tubular body, the mechanical balloon comprising a series of arms disposed along the longitudinal axis of the tubular body, each arm having a proximal end attached to a first ring and a distal end attached to a second ring, wherein the second ring is fixed to the tubular body; and a third ring disposed around the tubular body proximal to the first ring, the third ring adapted to move along the tubular body to engage the first ring and push the first ring toward the distal end of the tubular body, thereby placing a load on the arms and causing them to flare out from the tubular body. The mechanical balloon may also be used in combination with a compression flange or a bolster cone.


Optionally, the arms comprise a semi-rigid material. In some embodiments, each of the arms further comprises an articulating joint along the length of the arm.


In another embodiment, the surgical access port system comprises an outer ring, wherein the outer ring is configured to be disposed proximate the natural orifice of the patient; a tubular body having a longitudinal axis, a proximal end and a distal end; a funnel segment extending between and coupling the outer ring and the proximal end of the tubular body, wherein the funnel segment provides a diametric reduction between the outer ring and the tubular body; and an inflatable saddle-shaped balloon disposed around the tubular body, the saddle-shaped balloon comprising a first peak and a second peak, the second peak displaced from the first peak along the longitudinal axis of the tubular body. In some embodiments, the saddle-shaped balloon is adapted to compress the tissue of the natural orifice between the first peak and the second upon inflation to thereby occlude the natural orifice.


In another embodiment, the surgical access port system comprises an outer ring, wherein the outer ring is configured to be disposed proximate the natural orifice of the patient; a tubular body having an exterior surface, a longitudinal axis, a proximal end and a distal end; a funnel segment extending between and coupling the outer ring and the proximal end of the tubular body, wherein the funnel segment provides a diametric reduction between the outer ring and the tubular body; a retaining sleeve, the retaining sleeve comprising a longitudinal axis, a proximal end, a distal end, and a lumen, wherein the tubular body is disposed within the lumen and adapted to move along the longitudinal axis of the retaining sleeve; and at least two arms, each arm connected to the distal end of the retaining sleeve with an articulating hinge, wherein the arms are movable from a closed position to an open position as the distal end of the tubular body engages the arms.


Optionally, each arm further comprises an angled lead near the articulating hinge, the lead positioned to engage the distal end of the tubular body as the tubular body is moved through the retaining sleeve. In some embodiments, the access port further comprises an external thread wrapped around the exterior of the tubular body and an internal thread wrapped around an interior surface of the lumen of the retaining sleeve, wherein the external thread is adapted to engage the internal thread. In other embodiments, the access port further comprises a plurality of teeth disposed along the exterior surface of the tubular body and a plurality of pawls disposed along an interior surface of the lumen of the retaining sleeve, wherein the teeth are adapted to engage the pawls to facilitate unidirectional movement of the tubular body through the lumen of the retaining sleeve.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a side view of a patient in surgery illustrating an embodiment of the access device positioned on the abdomen and in use.



FIG. 2 is a cross-sectional side view illustrating an embodiment of the access device, with the wound retractor retracting the vagina of a patient, and the gel cap sealing the opening of the wound retractor.



FIG. 3 is a front view illustrating an embodiment of the access device deployed and in use at the mouth of the patient.



FIG. 4 is a top view illustrated a patient in the prone position with an embodiment of the access device deployed and in use at the anus of the patient.



FIG. 5A is a picture of the components of an access device system useful for natural orifice surgery; FIG. 5B is a perspective view of the retractor of FIG. 5A.



FIG. 6A is a perspective view of an embodiment of a natural orifice retractor having an occlusion flange. FIG. 6B is a side cut away of the natural orifice retractor of FIG. 6A.



FIG. 6C is a side view of an embodiment of a natural orifice retractor having a compression flange. FIG. 6D is a side cut away of the natural orifice retractor of FIG. 6C.



FIG. 6E is a perspective view of an embodiment of a natural orifice retractor having a bolster cone.



FIG. 6F is a side view of an embodiment of a natural orifice retractor having a mechanical balloon, shown in an uncompressed state. FIG. 6G is a side view of the natural orifice retractor of FIG. 6F, shown in a compressed, or expanded, state.



FIG. 6H is a perspective view of an embodiment of a natural orifice retractor having a balloon.



FIG. 6I is a perspective view of an embodiment of a natural orifice retractor having a saddle balloon.



FIG. 6J is a perspective view of an alternative embodiment of a retractor having an inflatable member.



FIG. 6K is a cutaway side view showing the check valve and channel disposed in the tubular body of the retractor.



FIG. 6L is a perspective view of an embodiment of a natural orifice retractor having a balloon and a bolster.



FIG. 6M is a perspective view of an embodiment of a natural orifice retractor adapted to provide retraction and access without insufflation, shown in an open configuration. FIG. 6N is a cross-sectional view of the embodiment of a natural orifice retractor of FIG. 6M. FIG. 6O is a close-up side view of the screw threads disposed around the retaining sleeve and the tubular body of the retractor. FIG. 6P is a cross-sectional view of the embodiment of FIG. 6M, shown in a closed configuration.



FIG. 6Q is a close-up side view of the ratcheting mechanism for attaching the retaining sleeve to the tubular body of the retractor.



FIG. 7A is a perspective view of an obturator adapted to facilitate introduction of a natural orifice retractor into a body orifice such as a vagina. FIG. 7B is a side view of the obturator of FIG. 7A.



FIG. 7C is a perspective view of an obturator having a straight shaft piece, adapted to facilitate introduction of a natural orifice retractor into a body orifice such as a vagina. FIG. 7D is a perspective view of a retractor disposed on the obturator of FIG. 7C.



FIG. 7E is a perspective view of an obturator, modified with an indent to provide clearance for the inflation port shown in FIGS. 6I and 6J and adapted to facilitate introduction of a natural orifice retractor into a body orifice such as a vagina.



FIG. 8A is a side view of the natural orifice access device of FIG. 5A. FIG. 8B is a top view of the natural orifice access device illustrated in FIG. 5A. FIG. 8C is a perspective view of the natural orifice access device illustrated in FIG. 5A.



FIG. 9A is a perspective view of an embodiment of a natural orifice access device including a cap having a plurality of ports extending there through.



FIG. 9B is an exploded view of an embodiment of a port and optional obturator, which is a component of some embodiments of the access device system.



FIG. 10A is a top perspective view of an embodiment of a gel cap. FIG. 10B is a bottom view of an embodiment of a cap ring.



FIG. 11A is a top view of an embodiment of a gel cap comprising a plurality of access ports embedded in the gel pad. FIG. 11B is a top perspective view of the gel cap illustrated in FIG. 11A. FIG. 11C is a bottom perspective view of the gel cap illustrated in FIG. 11A.



FIG. 11D is a top perspective view of the gel cap illustrated in FIG. 11A with instruments inserted through two of the access ports. FIG. 11E is a bottom perspective view of the gel cap and instruments illustrated in FIG. 11D. FIG. 11F is a side view of the gel cap and instruments illustrated in FIG. 11D.



FIG. 11G is a top perspective view of an embodiment of gel cap comprising a fixed camera or laparoscope port.



FIG. 12 is a cutaway perspective view of an embodiment of an access device system comprising a gel cap that snap fits to a retractor.



FIG. 13 is an exploded view of an embodiment of a trocar.



FIGS. 14A and 14B are side views of an embodiment of a trocar comprising a fixation cannula in an insertion configuration and a fixation configuration, respectively.



FIG. 15 is a side view of another embodiment of a trocar comprising a fixation cannula.



FIG. 16A is a side view of another embodiment of a trocar comprising a fixation cannula. FIG. 16B is a perspective view of an embodiment of a bolster suitable for use with the trocar illustrated in FIG. 16A.



FIG. 17A is a side view of another embodiment of a trocar comprising a fixation cannula. FIG. 17B is a perspective view of an embodiment of a bolster suitable for use with the trocar illustrated in FIG. 17A.





Similar components have similar reference numbers throughout.


DETAILED DESCRIPTION OF CERTAIN EMBODIMENTS

Embodiments of a surgical instrument access device system are useful, for example, for single incision, single port, and/or limited port laparoscopic surgical procedures, for example, abdominal (FIG. 1), transvaginal (FIG. 2), transoral (FIG. 3), and transanal (FIG. 4) procedures. Various surgical instrument access devices are described in U.S. Patent Application Publication No. 2009/0187079, entitled “SURGICAL INSTRUMENT ACCESS DEVICE,” filed Jan. 22, 2009, and U.S. Pat. No. 7,727,146, entitled “WOUND RETRACTOR WITH GEL CAP,” both of which are incorporated by reference in their entireties herein.



FIG. 5A shows an embodiment of an access device system comprising a retractor 6100, an introducer 6400 shown inserted into the retractor as if for placement in a body orifice, a cap 6200, one or more ports 6310, and an obturator 6600, which is useful in single port and/or limited port procedures. The retractor 6100 is placed and/or positioned into, across, and/or through a surgical incision and/or body orifice to enlarge, reshape, and/or isolate the incision or body orifice. The cap 6200 provides an artificial body wall through which instruments access the interior of a patient's body, for example, a body cavity, through ports 6310. The retractor 6100 may be introduced into an orifice using the introducer 6400; ports 6310 may be placed through the gel cap using obturator 6600. The components of the access device comprise any suitable biologically compatible materials.


With the gel cap 6200 attached to the retractor 6100, the access device system allows the user to insufflate the orifice, such as the vaginal canal. The distention of the canal caused by the insufflation provides greater visualization of the anatomy (when compared, for example, to traditional vaginal hysterectomy) and removes the need for the use of rigid mechanical retractors which may cause damage to soft tissues. The gel cap may be detached at any point during the surgical procedure to allow for specimen removal.


The retractor 6100 is made of a semi-pliable thermoplastic elastomer or thermoset polymer. For use in vaginal procedures, a length of approximately 4 cm to 7 cm and a diameter of approximately 3 cm to 5 cm will suit a range of anatomies. The retractor retracts and occludes the vagina. Suture ties 6160 at proximal end 6152 and/or a flange 6110 along the tubular body may help prevent the retractor from dislodging once placed. The gel cap 6200 may be attached with the aid of a lever 6135 which locks under the proximal ring 6120 of the retractor 6100. This creates a pressure resistant seal and insufflation is possible through insufflation ports 6145 on the gel cap. Smoke evacuation is possible through the port not being used for insufflation. Instrument ports 6310 may be placed in the gel cap 6200 to allow for the use of various laparoscopic instruments. The gel cap may then be detached and specimens may be removed through the retractor 6100.


Turning to FIG. 5B, the outer ring 6120 is proximal a funnel section 6140. In the illustrated embodiment, the outer ring 6120 has a substantially circular footprint. As further discussed herein, the outer ring 6120 can be sized and configured to sealingly couple to a cap or other access device thereon. In some embodiments, one or more suture points 6160 can be disposed on the retractor 6100 adjacent the outer ring 6120. Two suture points 6160 are generally diametrically opposed relative to the generally circular profile of the outer ring 6120. In other embodiments, the retractor can include more or fewer than two suture points disposed of various locations relative to the outer ring 6120.


With continued reference to FIG. 5B, the tubular body 6130 has a generally circular profile defining a generally cylindrical passage 6150. The generally cylindrical passage is desirably large enough to accommodate more than one laparoscopic instrument there through such that a single natural orifice access device can be used to provide access for multiple surgical instruments in a body cavity. Moreover, generally cylindrical passage is desirably large enough such that multiple surgical instruments positioned there through can be translated or pivoted relative to one another, allowing a surgeon to manipulate the instruments as desired during a surgical procedure. The generally cylindrical passage extends between a proximal end 6152 of the retractor 6100 adjacent the outer ring 6120 to a distal end 6154 of the retractor 6100 adjacent the flange 6110. In FIGS. 5A and 5B, the tubular body 6130 has a circular cross-section. In other embodiments, the tubular body 6130 has another shape, for example, an oval cross section, an octagonal cross-section, or other shapes as may be appropriate for the natural orifice of interest. Some embodiments of the tubular body 6130 comprise one or more coatings that provide additional functionality, for example, an anti-microbial coating.


In the illustrated embodiment, the funnel segment 6140 provides a diametric reduction between the relatively large diameter of the outer ring 6120, which is sized and configured to be removably coupled to an access device such as a cap, and the relatively smaller diameter of the passage 6150, which is sized to fit within a natural orifice with minimal distention of the orifice. The funnel segment 6140 has an inner surface which can provide a bearing surface for an obturator or introducer used to advance to the retractor 6100 into a body cavity. In some embodiments, the funnel segment can have a substantially linear taper between the relatively large diameter and the relatively smaller diameter such that the inner surface is a frustoconical segment. In other embodiments, the funnel segment 5 can have a curved profile between the relatively large diameter and the relatively smaller diameter. In some embodiments, there is no funnel section at all, as where the tubular body connects directly to the outer ring.


It can be desirable that the outer ring 6120 is relatively stiff compared with the relatively flexible tubular body 6130 of the retractor 6100 so that the outer ring 6120 can sealingly engage an access device such as a cap. With reference to FIG. 5B, a perspective view of the retractor is illustrated with a partial cutaway of the outer ring 6120. In the illustrated embodiment, the outer ring 6120 includes an annular groove 6122 formed therein in which a reinforcing member 6124 is disposed. In some embodiments, the reinforcing member 6124 can comprise a metallic member such as a wire formed into a ring shape. For example, in some embodiments the reinforcing member 6124 can comprise a stainless steel ring positioned within the groove 6122 during manufacture of the retractor 6100. In other embodiments, the reinforcing number 6124 can comprise an injectable nonmetallic member. For example, in some embodiments, a glass filled polymer or polycarbonate material can be injected into the groove 6122 during manufacture of the retractor 6100.


While the illustrated embodiments of retractor 6100 include a reinforcing member to enhance the rigidity of the outer ring 6120, in other embodiments, the retractor 6100 can be formed in a multiple-shot molding process. For example, in some embodiments, an inner segment of the retractor defined by the tubular body 6130 and the flange 6110 is formed in one molding operation from a flexible material, and an outer segment of the retractor 6100 defined by the funnel segment 6140 and the outer ring 6120 is formed in another molding operation from a relatively rigid material such as a polycarbonate material or other suitable material.


With continued reference to FIG. 5B, the illustrated embodiment includes a continuous generally annular groove. In other embodiments, a plurality of noncontiguous recesses can each receive one of a plurality of reinforcing members. Moreover, in some embodiments, the outer ring can include two or more concentric generally annular grooves, which each receive a corresponding reinforcing member.


Various types of flanges may be used to help secure the retractor in the body orifice. One embodiment of the natural orifice access device retractor 6100 illustrated in FIG. 6A can be adapted for use in a transvaginal surgical procedure. The retractor 6100 comprises an occlusion flange 6111, an outer or proximal ring 6120, and a tubular body 6130 and a funnel segment 6140 extending between and coupling the occlusion flange 6111 and the outer ring 6120. The occlusion flange 6111 is semi-rigid, with a diameter from approximately 2 inches to 4 inches. When inserted into the orifice, for example, the vagina, the flange is under compression from the walls of the vaginal canal, creating a seal to aid in the maintenance of insufflation. In some embodiments, the occlusion flange is “cup-shaped” with a circular ridge 6109 circumscribing a channel 6107, which provides sufficient flexibility to allow the flange 6111 to flex to accommodate different anatomies while still maintaining a seal.


With reference to FIG. 6C, a side view of a retractor 6100 for use in the natural orifice access device system having a different flange embodiment is shown. In this embodiment, the retractor 6100 is shown with a compression flange 6112. The compression flange 6112 is approximately 2 inches to 4 inches in diameter and is disposed around the retractor distal to the outer or proximal ring 6120. The distance between the compression flange and the outer ring is designed to be less than the thickness of the tissues comprising the natural orifice opening. In the case of the vaginal opening, the distance is approximately 0.1 inches to 0.5 inches. This creates a compressive force on the tissue between the flange and outer ring of the retractor. This force and the “cup-shaped” geometry of the flange (see FIG. 6D) occlude the vagina and serve to prevent dislodging. Suture ties 6160 may be used to mitigate dislodging.


With reference to FIG. 6E, a perspective view of a retractor 6100 for use in the natural orifice access device system having still another flange embodiment is shown. In this embodiment, the retractor 6100 is shown with a bolster cone 6113. The soft thermoset polymer or thermoplastic elastomer bolster cone (tapered with maximum diameter approximately 2 inches to approximately 4 inches for use in the vagina) may be added to the retractor. In use, the retractor is advanced into the body orifice, such as a vagina, while the bolster cone serves as a stop to externally occlude the vagina. The bolster cone may be fixed or mobile along the tubular body 6130 of the retractor 6100. The suture ties 6160 prevent the retractor from dislodging and maintain compression of the bolster cone against the orifice opening. The design may optionally include a flange similar to others described herein.


With reference to FIGS. 6F and 6G, a side view of a retractor for use in the natural orifice access device system having a different flange embodiment is shown. In this embodiment, the retractor is shown with a mechanical expanding feature (a “mechanical balloon”) 6114. The mechanical balloon comprises a series of arms 6105 that run circumferentially around the channel 6130, the arms attached at to a first ring 6103 and a second ring 6101. The first ring is movable along the length of the channel, while the second ring is fixed at or near the distal end of the channel. A sliding third ring 6102, disposed around the tubular channel proximal to the first ring, may be advanced toward the distal end of the channel, putting the arms under a load that causes them to flare outwards to assume a balloon-like shape, shown in FIG. 6G. The arms exert a force on the anatomy of the natural orifice, causing the retractor to be anchored in place without damaging the surrounding tissue.


In some embodiments, the sliding third ring is threaded along its interior surface and is adapted to engage with threads disposed around the channel. See FIG. 6G. In other embodiments, a ratcheting mechanism may be used to move the sliding third ring along the channel.


The sliding ring may comprise any rigid or semi-rigid material, plastic or metal, while the arms may comprise a semi-rigid metal or plastic sufficiently flexible to flare outwards under a load. Alternatively, the arms may comprise a rigid material with an articulating joint located approximately mid-length of each arm, facilitating a similar flaring.


The mechanical balloon has a diameter of approximately 2 inches to approximately 4 inches and is disposed around the tubular body at the distal end of the retractor. The mechanical balloon may be coated in a non-porous, flexible material to permit occlusion and prevent dislodging when expanded or non-coated to serve solely for fixation. The amount of expansion may be variable to accommodate different anatomies. The feature is initially unexpanded to ease insertion and is then expanded as needed.


In some embodiments, the mechanical balloon may be used in combination with a compression flange as shown in FIG. 6C. In this embodiment, the compression flange is disposed around the tubular body proximal to the mechanical balloon and helps seal the retractor within the natural orifice. In an alternative embodiment, the mechanical balloon may be used in combination with a bolster cone, as shown in FIG. 6E. The bolster cone will act to seal the retractor within the orifice while the mechanical balloon helps anchor it.


In other embodiments, shown in FIGS. 6H-J, the flange can comprise an inflatable member 6132 such as an annular balloon coupled to a gas or fluid source that can be selectively inflated and deflated between a deflated, relatively small diameter state for insertion and removal, and an inflated, relatively high diameter state for retention in a body cavity. An inflation port 6134, for example a check valve, affixed to the funnel portion 6140 of the retractor, is connected to the inflatable member 6132 through a channel 6136 within the wall of the tubular body 6130. Fluid or gas introduced through the inflation port flows through the channel into the inflatable member to thereby inflate the member.


The channel 6136 runs through the tubular body, generally parallel to the longitudinal axis of the tubular body, with a proximal opening interacting with the inflation port 6134 and a distal opening 6139 into outer surface of the tubular body at the inflatable member. In one aspect, the inflation port 6134 may include a normally closed check valve having a spring-loaded plunger. In a further aspect, the check valve may include a Luer lock. It is contemplated that other inflation ports that are well known in the art may be used.


In this embodiment, the tubular body 6130 is preferably comprised of a relatively rigid material, such as a polycarbonate. The tubular body has an inflatable member at the distal end that may be created by heat shrinking polyolefin tubing around the outside of the tubular body. The distal end of the body/tubing assembly is then heated for approximately 30 to 40 seconds, and then placed inside a mold and injected with air to give the inflatable member an annular balloon shape as seen in FIG. 6H, or any other desired shape, depending on the configuration of the mold. The inflatable member 6132 should have sufficient impermeability properties to substantially prevent inflation gas or fluid from permeating through a wall of the inflatable member.


In one embodiment, the inflatable member 6132 may include a substantially toroid shape upon inflation (see FIG. 6H). In another embodiment, the inflatable member may include a disc shape upon inflation. In another embodiment, the inflatable member 6132 may be a fluted balloon. In still another embodiment, the inflatable member is a saddle shaped balloon 6116, as shown in FIG. 6I. For use in vaginal surgery, the saddle shaped balloon in this embodiment is tapered with maximum diameter from approximately 2 inches to approximately 4 inches. The balloon is initially deflated for ease of entry into the vagina and then may be inflated by through an inflation port 6134 on the proximal end of the retractor. The vaginal opening seats in the low point of the saddle and is compressed between the peaks of the saddle as the balloon is inflated. This occludes the vagina, both internally and externally, and prevents dislodging. The balloon also distributes forces applied during the procedure over a greater area, reducing possible damage to tissue. Suture ties may also be used to mitigate dislodging. The balloon is then deflated upon completion of the procedure to ease removal. Other shapes suitable for particular natural orifices will be appreciated by one skilled in the art.


In use, the inflatable member may be inflated after the retractor is disposed within the natural orifice by inserting a syringe into the valve 6134 located at the proximal end 6138 of the channel within the tubular body (see FIG. 6K). As shown in FIGS. 6J and 6K, the port leads into the channel 6136, which allows the fluid or gas from the syringe to travel to the inflatable member 6132. Alternatively, a bulb pump or other source of gas or fluid may be used to inflate the inflatable member.


In still another embodiment, the bolster cone described herein may be combined with an inflatable member, as shown in FIG. 6L. In this embodiment, the retractor has a balloon 6132 at the distal end and a bolster cone 6113 mid-channel. For use in vaginal procedures, the balloon has a diameter from about 2 inches to about 4 inches while the bolster cone is tapered with a maximum diameter of about 2 inches to about 4 inches. The balloon 6132 is initially deflated for ease of entry into the vagina and then may be inflated through a port 6134 on the proximal end of the retractor. The amount of inflation may be variable to accommodate different anatomies. The balloon occludes the vagina when inflated and prevents the retractor from dislodging while causing compression of the bolster cone against the vaginal opening to further occlude. The bolster cone distributes forces applied during the procedure over a greater area, reducing possible damage to tissue. Suture ties may also be used to mitigate dislodging. The balloon is then deflated upon completion of the procedure to ease removal.


Another embodiment of the natural orifice access system, configured to provide retraction and access without using insufflation gases, is shown in FIGS. 6M-6P. In some natural orifices, for example, the vagina, pressure from a standard insufflator can be insufficient to maintain a visible, stable surgical working space due to leaks and billowing created by surges from the insufflator. In this embodiment, the retractor 6100 has a proximal ring 6120 and a tubular body 6130, with the tubular body adapted to engage a retaining sleeve 6143. The retaining sleeve includes a lip 6144 at the proximal end and at least two retracting arms 6146 at the distal end. The retracting arms are connected to the retaining sleeve with an articulating hinge 6147 that allows the arms to move between a closed position (FIG. 6P), in which the distal ends of the arms in proximity, and an open position (FIGS. 6M, 6N), in which the distal ends of the arms are moved away from each other. Optionally, the retracting arms may include an angled lead 6148 near the hinge 6147.


In the embodiment of FIGS. 6M-6P, the tubular body includes an external thread 6149 wrapped around the exterior of the tubular body, adapted to engage an internal thread 6151 disposed around the surface of the interior lumen of the retaining sleeve 6143. See FIG. 6O.


In an alternative embodiment, a ratcheting mechanism comprising teeth 6153 and a series of pawls 6155 may be used instead of internal and external threads (see FIG. 6Q). The ratchet mechanism allows the retractor to advance through the lumen of the retaining sleeve with relative ease while resisting backwards movement until the sides of the tubular body of the retractor are manually depressed to release the ratchet mechanism.


In use, the tubular body 6130 of the retractor 6100 is advanced forward through the lumen of the retaining sleeve 6143 until contact is made with the retracting arms 6146. The angled lead 6148 on the retracting arm allows for the opening to occur at an incremental rate to accommodate a variety of anatomies. The lip 6144 on the retaining sleeve ensures that the proximal end of the lumen will not enter the orifice and provides a holding point during the advancement of the retractor. As seen in FIGS. 6M and 6N, the fully advanced channel presses on the retracting arms, causing them to flare out and hold open the vaginal canal. With the tissue of the vaginal canal retracted, direct access is available to the cervix and surrounding tissue. In FIG. 6P, the retractor is drawn back; the retracting arms are disengaged and are able to fold together. This state facilitates insertion and removal from the orifice.


In some embodiments, a natural orifice access system can include a retractor 6100 and an optional obturator 6400 (FIG. 7A-7B). The obturator can have a proximal bearing surface 6410 sized and configured to bear against the inner surface 6142 of the funnel segment 6140 and a distal dilation surface 6420 sized and configured to expand a natural orifice for passage of the retractor 6100. Thus, during insertion of the retractor 6100 into a natural orifice, the dilation surface 6420 expands a pathway to a surgical site in a body cavity while the obturator bears on the inner surface 6142 of the funnel segment 6140 to advance the retractor 6100 into position in the surgical site. Furthermore, in some embodiments, the obturator can have a handle 6430 at a proximal end thereof adapted to facilitate selective twisting or rotation of the obturator about a longitudinal axis thereof during insertion.


In an alternative embodiment, shown in FIG. 7C, the obturator 6405 includes a straight shaft piece 6425 between the distal dilation surface 6420 and the proximal bearing surface 6410 that facilitates dilation of the natural orifice prior to inserting the retractor. It can then be combined with the retractor 6100 to help ease insertion, as shown in FIG. 7D.


In embodiments having an inflatable member on the retractor, the optional obturator 6400 may be modified with an indent 6139 to provide clearance for the inflation port, as shown in FIG. 7E.


With reference to FIG. 8A, a side view of a natural orifice access device having a cap 6200 removably coupled to a retractor 6100 is illustrated. In the illustrated embodiment, the cap 6200 comprises a sealable access surface 6210 such as a gel pad surface as described in further detail herein. In certain embodiments, the cap 6200 can also comprise at least one gas or fluid port 6220, 6230. In the illustrated embodiment, the cap 6200 comprises two gas or fluid ports 6220, 6230, such that one port can be used for gas insufflation and the other port can be used for ventilation for example when electrosurgery is performed through the access device. In certain embodiments, at least one of the gas or fluid ports 6220, 6230 comprises a valve such as a stopcock valve to selectively control the flow of fluid there through.


With reference to FIG. 8B, a top view of the natural orifice access device is illustrated. The sealable access surface 6210 can be encircled by and restrained by an annular frame 6240 such as a split ring having a clamp 6250. The clamp 6250 can be movable between an open configuration in which the cap 6200 is selectively removable from the retractor 6100 and a clamped configuration in which the cap 6200 can be secured to the retractor 6100. For example, the annular frame 6240 can be positioned peripherally around the outer ring 6120 with the clamp 6250 in the open configuration and the clamp moved to the clamped configuration to sealingly fix the cap 6200 to the retractor 6100. Accordingly, the cap 6200 can be easily removed during a surgical procedure to facilitate removal of excised tissue from a surgical site through the retractor 6100.


With reference to FIG. 8C, a perspective view of the natural orifice access device is illustrated. In the illustrated embodiment, the clamp 6250 can have a distal flange 6252 positioned to interface with the outer ring 6120 of the retractor when the clamp is in the clamped configuration. As illustrated, the clamp 6250 engages a distal surface of the outer ring 6120 of the retractor 6100. In some embodiments, the annular frame 6240 can further comprise at least one distal flange sized and positioned to interface with a retractor. In the illustrated embodiment, the annular frame 6240 comprises a distal flange 6260 positioned to engage a distal surface of the outer ring 6120 of the retractor. As illustrated, the flange 6260 is generally diametrically opposed to the distal flange of the clamp 6250. In other embodiments, the annular frame 6240 can include more than one distal flange positioned substantially equally spaced about the periphery of the annular frame 6240 or spaced irregularly about the periphery of the annular frame.


With reference to FIG. 9A, another embodiment of natural orifice access device is illustrated with a cap 6300 removably coupled to a retractor 6100. In the illustrated embodiment, the cap 6300 includes multiple ports 6310 positioned through an access surface 6320 thereof. Advantageously, the multiple ports 6310 allow for easy placement and manipulation of multiple laparoscopic instruments in a surgical site through a single natural orifice.


In the illustrated embodiments of FIG. 9A, the ports 6310 have a relatively low profile, that is, protrude minimally above the access surface 6320 and/or below the distal surface of the cap 6300. Accordingly, the ports 6310 are shorter than a length of a typical trocar and comprise a seal assembly positioned above the access surface 6320 and a cannula extending through the gel pad of the cap 6300. The reduced length of the ports 6310 allows increased angular or pivotal motion for instruments extending there through, and also permits the use of curved and/or angled instruments.



FIG. 9B is an exploded view of an embodiment of a port 6310 and optional obturator 6600, which is a component of some embodiments of the access device system. In the illustrated embodiment, the obturator 6600 comprises a pointed, puncture tip 6610.


The port 6310 comprises a proximal end, a distal end, and a longitudinal axis. The port 6310 comprises a cannula 6620 extending along the longitudinal axis. A seal 6630 is disposed at the proximal end of the cannula 6620, contained within a housing 6640. A retainer 6650 is disposed at the distal end or tip of the cannula 6620.


The cannula 6620 comprises a tubular body dimensioned to accommodate an instrument or instruments received there through. In the illustrated embodiment, the cannula 6620 is a substantially cylindrical tube, and extends through the cap 6300 in use. In the illustrated embodiment, the cannula 6620 is comparatively short because the cannula need only traverse the cap 6300 (FIG. 9A), which has a known and consistent thickness, rather than a body wall. Accordingly, some embodiments of the cannula 6620 are not more than about 2-times longer, about 1.5-times longer, about 1.2-times longer, or about 1.1-times longer than the thickness of the gel pad. In some embodiments, the cannula 6620 is less than about 20 mm, about 10 mm, or about 5 mm longer than the thickness of the gel pad. In some embodiments, the cannula 6620 is about as long as the gel pad is thick. In other embodiments, the cannula 6620 has a different length, for example, a length typical for a cannula used for traversing a body wall. Shorter length cannula permit increased angular degrees of freedom for instruments passing there through. Embodiments of shorter cannula also accommodate curved instruments. The cannula 6620 comprises any suitable biocompatible material. In some embodiments, the cannula 6620 comprises a flexible material.


The illustrated seal 6630 comprises an instrument or septum seal 6660 and a zero seal 6670. Optionally, a shield 6680 may be disposed within the instrument seal 6660. The instrument seal 6660 seals instruments passing there through, thereby maintaining pressurization in a body cavity such as pneumoperitoneum or pneumorectum. The zero seal 6670 provides a seal when no instrument passes through the seal 6630. The instrument seal 6660 and zero seal 6670 are received in a housing 6640 disposed at the proximal end of the cannula 6620 and secured therein by a seal cover 6690.


The retainer 6650 is disposed at or near the distal end of the cannula 6620. In some embodiments, the retainer 6650 and cannula 6630 are integrated, while in other embodiments, the retainer 6650 and cannula 6630 are not integrated. In the illustrated embodiment, the proximal end of the retainer 6650 comprises a flange 6655 that is generally flat and perpendicular to the longitudinal axis, while the distal end is tapered, narrowing toward the distal end of the cannula 6620. The flange 6655 reduces the likelihood of accidental or inadvertent removal of the port 6310 from the cap. Some embodiments of the proximal face of the flange 6655 comprise additional anchoring features, for example, at least one of barbs, spikes, ridges, texturing, and the like, which are configured to penetrate or bite into a distal face of the cap 6300. In some embodiments, a diameter of the flange 6655 is from about 1.2 to about 2.5 times wider, or from about 1.5 to about 2.0 times wider than an outer diameter of the cannula 6630. Some embodiments of the port 6310 are 5-mm trocars, in which the outer diameter of the cannula 6620 is from about 7 mm to about 8 mm.


The tapered end of the retainer 6650 facilitates insertion of the port 6310 through the cap, either by itself, or when assembled with the obturator 6600 extending there through. For example, in some embodiments, the retainer 6650 is inserted through a preformed opening in the cap 6300.


In some embodiments in which the retainer 6650 and cannula 6620 are not integrated, that is, are separate components, the retainer 6650 is secured to the cannula 6620 after the cannula 6620 is inserted through the cap. In some embodiments, the cannula 6620 and retainer 6650 are secured mechanically, for example, using latches, screw threads, clips, lock rings, ratchets, and the like. In some embodiments, the cannula 6620 and retainer 6650 are secured adhesively. In some embodiments, the position of the retainer 6650 is adjustable, for example, to accommodate caps of different thicknesses. In some embodiments, the cannula 6620 and/or retainer 6650 is secured to the cap, for example, adhesively.



FIG. 10A illustrates in perspective an embodiment of a cap or cover 10500, which is a surgical access device that seals the opening between the body cavity and the area outside the body cavity while providing access into the body cavity from outside the body cavity. More particularly, the illustrated cap 10500 releasably and sealingly couples to the outer ring 6120 (FIG. 5), of the wound retractor. The cap 10500 comprises a cap ring 10510 dimensioned and configured for coupling to the outer ring 6120 of the wound retractor and a pad 10530 coupled to the cap ring 10510. Embodiments of the cap 10500 provide an artificial body wall with consistent properties compared with a natural body wall, for example, thickness, compliance, rigidity, uniformity, and the like.


The illustrated cap or cover 10500 is substantially circular. In other embodiment, the gel cap 10500 has another shape or footprint, for example, oval, elliptical, parabolic, square, rectangular, or another suitable curved or polygonal shape. In some embodiments, the outer ring 6120 of the retractor and cap ring 10510 of the cap have the same general shape or footprint. In other embodiments, the outer ring 6120 of the retractor and cap ring 10501 of the cap have substantially different shapes, for example, a generally circular outer ring 6120 and an oval cap ring 10510. In these embodiments, the outer ring 6120 is distorted or reshaped for coupling to the cap ring 10510, for example, by compressing opposed sides of the outer ring 6120. Non-circular shapes are useful, for example, for procedures in which space is limited. As discussed above, retracting a long, straight incision using an oval or elongated retractor requires less force than a similar procedure using a circular retractor.


In some embodiments, the pad 10530 comprises a gel. In such embodiments, the pad 10530 is referred to as a “gel pad” and the cap 10500 is referred to as a “gel cap”. Descriptions of gel pads and gel caps generally apply to embodiments in which the pad 10530 does not comprise gel unless otherwise specified. In some embodiments, the gel pad 10530 does not comprise any preformed access channels there through, for example, for instrument access. Instruments may be inserted directly through the gel pad 10530, puncturing the gel pad 10530, and thereby creating access channels or portions in the gel pad 10530. Each access portion forms an instrument seal in the presence of an instrument inserted there through and a zero seal in the absence of an instrument inserted there through. The gel provides a gas tight seal around a variety of shapes and sizes of instruments inserted there through. Some embodiments of the gel pad 10530 also provide trocar access directly there through, which also provide instrument access into the body cavity. Embodiments of the gel pad 10530 have a working diameter of from about 40 mm to about 120 mm, which is the diameter of a portion of the gel pad 10530 through which instruments and/or trocars may be inserted. Embodiments of the gel cap 10500 are typically from about 10 mm to 50 mm wider than the working diameter.


Accordingly, embodiments of the gel cap 10500 maintain pressurization within a body cavity such as pneumoperitoneum or pneumorectum during multiple instrument exchanges and substantially prevent unintentional loss of pressurization. Embodiments of the gel cap 10500 also provide substantially continuous access and visibility during surgery. Embodiments of the gel cap 10500 have a small profile for use in procedures with limited surgical space.


In some embodiments, the gel is an ultragel, which is characterized by an ultimate elongation greater than about 1000 percent and a durometer less than about 5 Shore A. Some embodiments of the ultragel comprising KRATON® and mineral oil exhibit an ultimate elongation exceeding about 1500 percent and improved sealing properties, for example, sealing with instruments of a wider size range than other seal materials. In some embodiments, the seals comprising ultragels also form zero seals when the instrument is removed therefrom. Accordingly, in some embodiments of seals comprising ultragels, a single seal is acts as both the instrument seal as well as the zero seal.


Some embodiments of the cap ring 10510 comprise a substantially cylindrical ring comprising a proximal portion, a distal portion, and a longitudinal axis extending from the proximal portion to distal portions. In other embodiments, the cap ring 10510 has another shape or footprint, for example, oval. As best seen in FIG. 10B, which is a bottom view of a cap ring 10510, in the illustrated embodiment, the proximal portion of the cap ring 10510 comprises a plurality of apertures 10512 distributed about the periphery thereof. The apertures 10512 extend through a wall 10514 at the proximal portion of the cap ring. In other embodiments, the apertures 10512 are disposed in at least one member extending either longitudinally inward or longitudinally outward from the wall 10514 of the cap ring. The gel pad 10530 is disposed at the proximal portion of the cap ring 10510 in the illustrated embodiment, with portions of the gel pad 10530 extending through the apertures 10512, thereby creating an interlocking structure between the cap ring 10510 and the gel pad 10530, mechanically locking the cap ring 10510 and the gel pad 10530 together.


The distal portion of the cap ring 10510 is substantially cylindrical in the illustrated embodiment, and is dimensioned and configured to receive the outer ring 6120 (FIG. 5) of the wound retractor. The cap ring 10510 comprises a latch mechanism 10516 that removably couples the cap ring 10510 to the outer ring 6120. Those skilled in the art will understand that other mechanisms are also useful for coupling the cap ring 10510 to the outer ring 6120 of the wound retractor, for example, protruding lips, levers, clips, latches, tongues, grooves, screw threads, bayonet mounts, screws, friction fittings, compression fitting, snap caps, and the like. In the illustrated embodiment, when the outer ring 6120 of the wound retractor is received in the distal portion of the cap ring 10510, the outer ring 6120 of the wound retractor contacts and embeds within a portion of the gel pad 10530 disposed at the distal portion of the cap ring 10510, thereby displacing a portion of the gel, and forming a seal between the gel pad 10530, and the outer ring 6120 and tubular body 6130 of the wound retractor. Thus, the distal portion of the gel pad 10530 is in juxtaposition with the incision or body orifice. In other embodiments, the cap ring 10510 is permanently coupled or fixed to the outer ring 6120.


The cap ring 10510 in some embodiments comprises a polymer. Examples of suitable polymers include, at least one of polyethylene (PE), low density polyethylene (LDPE), high density polyethylene (HDPE), ultra high molecular weight polyethylene (UHMWPE), polycarbonate, thermoplastic elastomers (DYNAFLEX®, GLS Corp.; KRATON®, Kraton Polymers), polyphenylene oxide (PPO), polystyrene, and the like. The polymer component of the cap ring is fabricated by any suitable method, including injection molding, melt casting, blow molding, and the like.


Some embodiments of a process in which the gel pad 10530 is cast in the cap ring 10510 are include steps performed at temperatures above about 130° C. over several hours, for example, from about three (3) to about four (4) hours. Accordingly, in some of these embodiments, the cap ring 10510 does not deform under these conditions.


Some embodiments of the gel pad 10530 comprise an elastomeric gel. Examples of such gels are described in U.S. patent application Ser. No. 10/381,220, filed Mar. 20, 2003, the disclosure of which is hereby incorporated by reference as if set forth in full herein. Embodiments of the gel are prepared by mixing at least one triblock copolymer with a solvent that dissolves the midblocks of the triblock copolymer. The mixture is typically a slurry. The endblocks typically comprise a thermoplastic material, such as styrene, while the midblocks typically comprise a thermoset elastomer such as, ethylene/butylene, isoprene, or butadiene. Examples of the triblock copolymer include styrene-ethylene/butylene-styrene (SEBS), styrene-isoprene-styrene (SIS), and styrene-butadiene-styrene (SBS). In some embodiments, the solvent is an oil, for example, mineral oil. Upon heating a mixture or slurry of the triblock copolymer, the midblocks dissolve in the mineral oil, thereby forming a network of the insoluble endblocks. The resulting network has enhanced elastomeric properties compared with the parent copolymer. In some embodiments, the triblock copolymer used is KRATON® G1651, which has a styrene to rubber ratio of 33/67. Once formed, the gel is substantially permanent and, by the nature of the endblocks, processable as a thermoplastic elastomer henceforward. The mixture or slurry has a minimum temperature at which it becomes a gel, which is referred to as the minimum gelling temperature (MGT). This temperature typically corresponds to the glass transition temperature of the thermoplastic endblock plus a few degrees. For example, the MGT for a mixture of KRATON® G1651 and mineral oil is about 120° C. When the slurry reaches the MGT and the transformation to a gel state takes place, the gel becomes more transparent, thereby providing a visual endpoint confirming the complete transformation of the slurry to the gel state, whereupon the gel may be cooled. Some embodiments of the gel comprise a diblock copolymer, either instead of or in addition to the triblock copolymer. Embodiments of the diblock copolymer comprise a thermoplastic first endblock, for example, styrene, and a thermoset elastomeric second endblock, for example, ethylene/butylene, isoprene, or butadiene. An example of a suitable diblock copolymer is styrene-ethylene/butylene (SEB).


For a given mass of slurry to form a complete gel, the entire mass of the slurry is heated to or above the MGT and held at or above the MGT for a sufficient time for the end blocks to form a network or matrix of interconnections. The slurry will continue to form a gel at temperatures between the MGT and temperatures at which the components of the slurry/gel begin to decompose and/or oxidize. For example, when the slurry/gel is heated at temperatures above 250° C., the mineral oil in the slurry/gel will begin to be volatile and oxidize. Oxidizing may cause the gel to turn brown and become oily.


The speed at which a given volume of slurry forms a gel depends on the speed with which the entire mass of slurry reaches the MGT. Also, at temperatures higher than the MGT, the end block networks distribute and form more rapidly, thereby speeding the gel formation.


The various base gel formulas may also be mixed or alloyed with one another to provide gels with a variety of intermediate properties. For example, KRATON® G1701X is a mixture of seventy percent (70%) SEB and thirty percent (30%) SEBS, with an overall styrene to rubber ratio of 28/72. Those skilled in the art will appreciate that an almost unlimited number of combinations, alloys, and styrene to rubber ratios can be formulated, each providing and embodiment exhibiting one or more advantages, for example, low durometer, high elongation, and good tear strength.


Some embodiments of the gel material further comprise a polymer that, with a foaming agent, improves the sealing properties of the gel, for example, silicone, soft urethanes, and even harder plastics. Examples of suitable silicones include those used for electronic encapsulation. Examples of suitable harder plastics include polyvinylchloride (PVC), isoprene, KRATON® neat, and other KRATON®/oil mixtures. In the KRATON®/oil mixture, suitable oils include vegetable oils, petroleum oils, and silicone oils, as well as mineral oil.


Some embodiments of the gel comprise one or more additives that provide one or more desirable properties, for example, at least one of enhanced lubricity, improved appearance, and wound protection. Additives are incorporated directly into the gel and/or applied as a surface treatment. In some embodiments, other compounds are added to the gel to modify its physical properties and/or to assist in subsequent modification of the surface by providing bonding sites and/or surface charges. Additionally, oil-based colorants are added to the slurry to create gels of different colors in some embodiments.


Some embodiments of the gel pad 10530 comprise a layer of polyethylene on at least one surface. Polyethylene is dissolved in mineral oil and the solution applied to one or more surfaces of the gel pad 10530. The mineral oil does not evaporate, but instead, absorbs into the gel pad over time, leaving behind the polyethylene as a layer on the surface of the gel pad.


In some embodiments, the triblock copolymer/solvent mixture/slurry used to manufacture the gel pad 10530 comprises about ninety percent (90%) by weight of mineral oil and about ten percent (10%) by weight of KRATON® G1651. From a thermodynamic standpoint, this mixture behaves similarly to mineral oil. Because mineral oil has a relatively high heat capacity, transforming 0.45 kg (1 pound) of the slurry into a homogenous gel at about 130° C. may take from bout three (3) to about four (4) hours. Once formed, the gel can be cooled as quickly as practicable with no apparent deleterious effects on the gel. In some embodiments, the gel is cooled by cold-water immersion. In other embodiments, the gel is air-cooled. Those skilled in the art will recognize that other cooling techniques are used in other embodiments.


Certain properties of the KRATON®/oil gel will vary with the weight ratio of the components. In general, a higher proportion of mineral oil results in a softer gel, while a higher proportion of KRATON® results in a firmer gel. A too-soft gel exhibits excessive tenting or doming of the gel cap 10500 during surgery when a patient's body cavity is insufflated. Some embodiments of gels that are too soft also do provide an adequate instrument seal and/or zero seal. The gel should be sufficiently soft to provide an adequate seal both in the presence of an instrument and in the absence of an instrument, however.


On prolonged or extended sitting or standing, the copolymer, such as KRATON®, and the solvent, such as mineral oil, in the slurry may separate. The slurry may be mixed to greater homogeneity, for example, with a high shear mixer. Mixing the slurry may introduce or add air to the slurry, however. To remove air from the slurry, the slurry may be degassed. In some embodiments, the slurry is degassed under a vacuum, for example, within a vacuum chamber. In some embodiments, the applied vacuum is about 0.79 meters (about 29.9 inches) of mercury, or about one (1) atmosphere. Optionally, stirring or mixing the slurry under vacuum facilitates removal of the air. During degassing under vacuum, the slurry typically expands, then bubbles, and then reduces in volume. The vacuum is typically discontinued when the bubbling substantially ceases. Degassing the slurry in a vacuum chamber reduces the volume of the slurry by about ten percent (10%). Degassing the slurry also reduces oxidation of the finished gel in some embodiments.


Degassing the slurry tends to result in a firmer gel. A gel made from a degassed slurry comprising about 91.6% by weight of mineral oil and about 8.4% by weight of KRATON® G1651, an eleven-to-one ratio, has about the same firmness as a gel made from a slurry that is not degassed and that comprises about ninety percent (90%) by weight of mineral oil and about ten percent (10%) by weight of KRATON® G1651, a nine-to-one ratio.


Because mineral oil typically has a lower density than KRATON®, the two components will separate after mixing, with the less dense mineral oil rising to the top of the container. This phase separation typically occurs when transforming a static slurry into a gel over several hours. Consequently, the resulting gel is non-homogeneous, with a higher concentration of mineral oil at the top and a lower concentration at the bottom. The speed of separation is a function of the depth or head height of the slurry being heated. Factors relevant to the relative homogeneity of the gel include the mass of slurry, the head height, the temperature at which the gel sets, and the speed at which the energy is transferred to the gel.


The gel pad 10530 or gel cap 10500 are gamma sterilized in some embodiments, which is relatively and/or comparatively simpler to qualify compared with other sterilization process, for example, versus ethylene oxide. Gamma sterilization can cause large bubbles to form in the gel pad, however, which are cosmetic and/or aesthetic issues in the sterilized devices. Because bubbles typically comprise greater than ninety-nine percent (99%) room air, the dissolved air is advantageously removed from the slurry prior to transforming the slurry into a gel. For example, the slurry may be degassed under vacuum, as described above, then gelled by heating. Some bubbles may still form in the gel during gamma sterilization, but typically disappear over a period of from about twenty-four (24) hours to about seventy-two (72) hours. Typically, mineral oil at room temperature has about ten percent (10%) dissolved gas. As discussed above, removing air from the gel makes the gel firmer. This effect is counterbalanced by a softening of the gel by the gamma radiation during gamma sterilization, however.


In some embodiments in which the gel pad 10530 is gamma sterilized, the gel comprises about ninety percent (90%) mineral oil by weight and about ten percent (10%) KRATON® by weight. As stated above, degassing the slurry makes the gel firmer. The counteracting softening by the gamma radiation, however, results in a gel with substantially the same firmness as a gel comprising about ninety percent (90%) mineral oil by weight and about ten percent (10%) KRATON® by weight that is not degassed and gamma sterilized.


In some embodiments, the gel pad 10530 is coupled to, attached to, formed with, or integrated with the cap ring 10510 to provide a gas-tight seal between the cap ring 10510 and the tubular body 6130 (FIG. 5). The gel pad 10530 covers and seals the entire opening in the cap ring 10510, as well as covering substantially the entire wound or orifice opening. As stated above, the gel pad 10530 provides a gas tight seal around a variety of shapes and sizes of instruments inserted there through.


Embodiments in which a gel pad support structure of the cap ring 10510 comprises a thermoplastic elastomer, for example, DYNAFLEX® or KRATON®, and the gel pad 10530 comprises a similar thermoplastic elastomer, for example, KRATON®, exhibit improved adhesion between the gel pad 10530 and the cap ring 10510. The polystyrene component of KRATON® in the gel pad 10530 improves adhesion with polyphenylene oxide (PPO), polystyrene, and other similar polymers.


In some embodiments of cap rings 10510 comprising polycarbonate, the polycarbonate component of the cap ring 10510 does not bond with the gel pad 10530 at 130° C., which is a typical manufacturing temperature for a gel pad 10530 comprising KRATON®. Raising the temperature to about 150° C. for a few minutes during casting, however, bonds the gel pad 10530 to the cap ring 10510. It is believed that heating the gel pad 10530 and cap ring 10510 to a temperature at which both the polystyrene component of the gel and the polycarbonate are simultaneously above their melt points allows bonds to form there between. In other embodiments, the uncured gel and the cap ring 10510 are heated to near or at the glass transition temperature of the polycarbonate in the cap ring 10510, thereby bonding the gel pad 10530 to the cap ring 10510.


In some embodiments, the gel comprises mineral oil and the cap ring 10510 comprises a polymer that dissolves in mineral oil under the manufacturing conditions, for example, polyethylene (PE), low density polyethylene (LDPE), high density polyethylene (HDPE), and ultra high molecular weight polyethylene (UHMWPE). Using polyethylene (PE) as an example, PE has a higher molecular weight than mineral oil and dissolves in mineral oil at the temperatures used to cast the gel pad 10530. As such, as a portion of the PE in the cap ring 10510 dissolves in the mineral oil in the gel pad 10530 at the processing temperatures, for example, above about 130° C., a bond between the PE in the cap ring 10510 and gel pad 10530 is formed.


In an embodiment of a method for manufacturing a gel cap, the cap ring 10510 is placed into a mold that together with the cap ring 10510 includes a negative space in the desired shape of the gel pad and uncured gel is added to the mold. Sufficient uncured gel is then added to the mold to cover and fill the apertures 10512. The uncured gel flows through, fills, and remains within the apertures. Also, in some embodiments, the mold is filled with sufficient uncured gel to extend into the distal portion of the cap ring 10510. After the gel cures, the gel in the apertures connects and couples the gel on a first side of each aperture 10512 to the gel on a second side of the aperture, thereby mechanically locking the gel pad 10530 to the cap ring 10510.


Some embodiments include another method for coupling the gel pad 10530 to the cap ring 10510, either in addition to or instead of the mechanical interlocking discussed above. Such methods are useful, for example, for coupling separately formed gel pads or gel slugs 10530 and cap rings 10510. Some embodiments use a glue or adhesive to couple the gel pad 10530 to the cap ring 10510, for example, cyanoacrylate (SUPERGLUE® or KRAZY GLUE®). The glue is believed to bond to either the rubber or the styrene component of the triblock copolymer with a bond is frequently stronger than the gel material itself. Some embodiments use solvent welding in which a solvent dissolves a plastic in the cap ring 10510 and the polystyrene in the gel pad 10530. The solvent is applied to the gel pad 10530 and cap ring 10510 by any suitable method, for example, by spraying and/or by dipping. In effect, the solvent melts both the plastic of the cap ring 10510 as well as the polystyrene in the gel pad 10530, thereby forming a bond between the two, which remains after the solvent evaporates.


In an embodiment for manufacturing a gel cap 10500, the gel pad 10530 is cast into the cap ring 10510 to form the gel cap 10500. The cap ring 10510 is positioned in or placed into a mold cavity of a casting mold. Embodiments of the mold cavity include support for the annular walls of the cap ring 10510. Embodiments of the mold comprise a material with sufficient heat dissipation properties, for example, at least one of aluminum, copper, and brass. Those skilled in the art will recognize that other mold materials with lower heat dissipation properties will produce acceptable parts in some embodiments. Furthermore, some embodiments of the mold comprise active cooling elements, for examples, channels through which coolants are pumped.


The mold cavity and cap ring 10510 assembly is then filled with a desired amount of the triblock copolymer/mineral oil slurry such that the slurry contacts the cap ring 10510. In some embodiments, the slurry is preheated, for example, to about 52° C. (125° F.), which facilitates a complete filling of the mold cavity by the slurry, thereby reducing the probability of voids in the gel. Preheating the slurry to a temperature below the MGT reduces the viscosity of the slurry and allows the slurry to flow more easily. As stated above, some embodiments of the slurry are degassed in a vacuum before casting. In some embodiments, the slurry is also degassed after it is filled in the mold cavity to remove any air that may have been introduced during the filling of the mold cavity, as well as to facilitate flow of the slurry into voids in the mold. The mold, cap ring, and slurry are heated, for example, in an oven, until the slurry reaches a temperature of about 150° C. As stated above, the slurry turns into gel at about 120° C.; however, at about 150° C., the gel bonds to a polycarbonate cap ring 10510. Depending on the material used in the cap ring 10510, bonding may take place at a temperature other than about 150° C. In embodiments in which the cap ring 10510 is comprises a material with a lower melting point than the MGT, for example 120° C., the gel pad 10530 is molded separately as a gel slug, which is then bonded to the cap ring 10510 as discussed above.


When the transformation of the slurry into a gel is complete, for example, when the temperature of the gel pad reaches about 150° C., the gel cap 10500 is cooled, for example, by air-cooling, cold-water immersion, or another suitable method. At 150° C. the gel pad 10530 is soft and easily distorted. Distortions in the gel pad 10530 present during cooling would be set after cooling. Accordingly, in some embodiments, the gel cap 10500 is cooled within the mold, thereby reducing the likelihood of distorting the gel pad 10530. Factors affecting the cooling time include the size and configuration of the mold, the quantity of gel, temperature and quantity of cooling medium, the properties of the cooling medium, and the mold material. As an example, the cooling time for a particular gel cap 10500 may be about two (2) hours for air cooling and about fifteen (15) minutes for water cooling. Whether cooling with air or water, the final properties of the gel are substantially the same. The gel cap 10500 is typically cooled to about ambient room temperature, but may be cooled to a lower temperature if desired. At about 0° C., the gel hardens, which is useful, for example, in secondary operations such as when coupling separately manufactured gel pads 10530 and cap rings 10510. The gel cap 10500 may be removed from the mold at any time after the gel has set.


When removed from the mold, the gel pad 10530 typically has a tacky surface. Coating the gel pad 10530 with a powder, such as cornstarch, substantially reduces or eliminates the tackiness of the cured gel pad 10530.


As stated above, in some embodiments, the gel pad 10530 is molded separately from the cap ring 10510, and coupled to the cap ring 10510 in a secondary operation, for example, bonding. In some embodiments, the gel pad 10530 is molded as a gel slug with an outer perimeter smaller than the perimeter of the inner cylindrical wall of the cap ring 10510 and a height greater than the height of the cap ring 10510. Because the gel pad 10530 is molded separate from the cap ring 10510, the slurry need only be heated to the MGT, for example, about 120° C., to complete the transformation of the slurry into a gel, whereupon the gel becomes substantially transparent. As discussed above, the gel slug may be cooled, for example, to about 0° C., then placed within the inner cylindrical wall of the cap ring 10510.


In some embodiments, the gel slug is coupled to the cap ring 10510 through compression molding, in which the gel slug is compressed longitudinally, thereby expanding the outer perimeter of the gel slug and compressing the gel slug against the inner cylindrical wall of the cap ring 10510. The compressed gel slug and cap ring 10510 are then heated to a sufficient temperature for the polystyrene in the gel and the polymer of the cap ring 10510 to form bonds there between. Molding the gel slug separately from the cap ring 10510 followed by heat bonding the gel slug to the cap ring is especially useful in embodiments in which the cap ring 10510 comprises a material with a melting temperature lower than the MGT of the gel. In such situations, the gel slug can be molded separately and heat bonded to the cap ring 10510 without melting the cap ring 10510.


An embodiment of a method for retracting an incision or body orifice using the retractor 6100, 7100 is discussed in detail above. The method results in the outer ring 6120 of the retractor substantially in contact with the exterior surface of the body wall. The gel cap 10510 is then coupled to the outer ring 6120 of the retractor, thereby sealing the opening between the body cavity and the area outside the body cavity and allowing the surgeon to insufflate the body cavity.


As discussed above, embodiments of the gel cap 10500 comprise no preformed access channels in the gel pad 10530. In use, instruments may be inserted directly through the gel pad 10530, thereby creating access channels through the gel pad 10530. Each access channel created in the gel cap forms an instrument seal in the presence of an instrument passing there through because the gel provides a gas tight seal around a variety of shapes and sizes of instruments. When the instrument is removed from the gel pad 10530, the channel created in the gel pad by the instrument closes to form a zero seal.


Some embodiments of the cap use access devices such as trocars inserted through the gel pad 10530 for instrument access, in particular, where an access channel experiences repeated instrument manipulation, for example, insertion, removal, advancement, retraction, rotation and/or other manipulation. Each trocar inserted through the gel pad 10530 permits repeated introduction, removal, and/or manipulation of instruments there through.


In some embodiments, the gel cap 10500 initially comprises no access channels, and the surgeon is at liberty to determine the placement of instruments there through. Moreover, the surgeon has unlimited flexibility in the placement and repositioning of ports within the area of the gel cap 10500, as well as the option of selecting different trocar sizes for different clinical procedures. Being detachable, the gel cap 10500 allows for the removal of large specimens. Once removed, the gel cap 10500 can be re-coupled to the outer ring 6120 of the retractor, thereby restoring the seal and allow the surgeon to re-insufflate the body cavity.


Moreover, embodiments of the gel are deformable without losing physical integrity, and while maintaining substantially gas tight instrument seals with any instruments extending there through, as well as gas tight zero seals for any access channels without any instruments extending there through. Accordingly, embodiments of the gel cap 10500 permit both translational or positional, and angular or pivotal “float” or degrees of freedom for the instruments passing through the gel pad 10530. This float permits instrument motion both relative to the cap ring 10510 as well as relative to other instruments. In contrast, other single or limited port systems do not exhibit one or both translational or angular float for instruments.



FIG. 11A is a top view of an embodiment of a gel cap 11500 comprising a plurality of access ports, seals, or sealing valves disposed in the gel pad. FIG. 11B is a perspective top view of the gel cap 11500 mounted on a retractor. FIG. 11C is a perspective bottom view of the gel cap 11500 mounted on a retractor. The gel cap 11500 comprises a cap ring 11510 and a gel pad 11530, which are generally similar to the cap ring and gel pad of the embodiment described above.


The gel cap 11500 further comprises a plurality of access ports 11540, at least a portion of which is disposed within or embedded within the gel pad 11530. In the illustrated embodiment, the access ports 11540 have a low profile, that is, do not protrude or protrude minimally above the proximal surface of the gel pad 11530 and/or below the distal surface of the gel pad 11530. Accordingly, the lengths of the access ports 11540 are similar to the thickness of the gel pad 11530, which is shorter than a length of a typical trocar inserted in the gel pad 11530, which comprises a seal assembly positioned above the gel pad 10530, and a cannula extending through the gel pad 11530. The reduced length of the access port 11540 allows increased angular or pivotal motion for instruments extending there through, and also permits the use of curved and/or angled instruments. In the illustrated embodiment, the access ports 11540 are substantially permanent or non-removable under the conditions under which the gel cap 11500 is used. Trocars can also be inserted through the gel pad 11530 if additional ports are desired.


Each port 11540 comprises longitudinal axis extending from a proximal side to a distal side of the gel pad 11530, a first seal 11542 disposed at the proximal side of the gel pad 11530, and a second seal 11544 disposed distal to the first seal 11542. A sight of each of the ports or seals 11540 has an aperture through the gel pad 11530 and coincides with the longitudinal axis. In the illustrated embodiment, the first seal 11542 forms an instrument seal with an instrument extending there through and the second seal 11544 forms a zero seal in the absence of an instrument extending there through.


In the illustrated embodiment, the first seal 11542 comprises a septum seal. Each septum seal comprises an aperture 11546 there through that is slightly smaller than a cross-section of the smallest instrument to be inserted there through. The aperture 11546 of the septum seal is substantially aligned with the aperture through the gel pad and the longitudinal axis of the port 11540. When an instrument is inserted through the aperture 11546 of the septum seal, the aperture 11546 expands and engages the outer surface of the instrument, thereby forming a seal therewith. The septum seal comprises an elastomeric material that biases the aperture against an instrument is inserted there through. Those skilled in the art will understand that other types of instrument seals are used in other embodiments.


In the illustrated embodiment, the second seal 11544 comprises a double-duckbill valve, which functions as a zero-closure seal that provides a zero seal in the absence of an instrument inserted there through. Those skilled in the art will understand that the second seal comprises another type of seal, for example, a duckbill valve, a flap valve, and the like. The double-duckbill valve comprises as elastomeric material. In some embodiments, each of the first seal 11542 and the second seal 11544 independently comprise an elastomeric material, for example, at least one of rubber, synthetic rubber, silicone, ethylene propylene diene monomer (EPDM), ethylene-propylene copolymer (EP rubber), polyisoprene, polybutadiene, polyurethane, styrene-butadiene, ethylene vinyl acetate (EVA), polychloroprene (NEOPRENE®), perfluorelastomer (KALREZ®), and the like


Thus, during use, the septum seal provides an instrument seal in the presence of an instrument inserted there through, and the duckbill valve provides a zero seal in the absence of an instrument inserted there through. The illustrated embodiment comprises ports or seals 11540 in the gel pad of different sizes. Each size of port 11540 sealing accommodates a different range of instrument sizes inserted there through. The size of a port is typically given as the diameter of the largest instrument that the port will accommodate, for example, 5 mm, 11 mm, or 12 mm. FIGS. 11D, 11E, and 11F are a perspective top view, a perspective bottom view, and a side view of a thinner instrument 11550a and a thicker instrument 11550b inserted through a smaller port 11540a and a larger port 11540b, respectively, of the embodiment of the gel cap 11500 illustrated in FIGS. 11A-11C.



FIG. 11G is a top perspective view of an embodiment of a gel cap 11500 further comprising a fixed port position, for example, for a camera or a laparoscope. The fixed port 11560 comprises a lock mechanism 11562 that maintaining the position of a camera or laparoscope inserted there through. In some embodiments, one of the ports 11540 further comprises a stopcock and/or gas fitting used as a gas inlet and/or outlet port for insufflating, depressurizing, and/or venting the body cavity of gas. In some embodiments, a gas inlet/outlet port is disposed on the cap ring 11510.



FIG. 12 is a cutaway perspective view of an embodiment of an access device system 12000 comprising retractor 12100 and a cap or cover 12500, which are similar to embodiments of retractors and gel caps described above. The retractor 12100 comprises an inner ring 12110, an outer ring 12120, and a sleeve 12130 extending between the inner ring 12110 and the outer ring 12120. In the illustrated embodiment, the cap 12500 is a gel cap comprising a proximal side, a distal side, a cap ring 12510, and a gel pad 12530. In the illustrated embodiment, the cap ring 12510 comprises a tubular ring dimensioned to receive the outer ring 12120 of the retractor therewithin. The distal side of the cap ring 12510 comprises an annular slot 12520, which is sufficiently radially deformable for the outer ring 12120 to reversibly pass there through. Accordingly, the illustrated embodiment of the cap ring 12510 secures the cap 12500 to the outer ring 12120 with a snap or friction fit.



FIG. 13 is an exploded view of an embodiment of a trocar 13800 and optional obturator 13900, which is a component of some embodiments of the access device system. In the illustrated embodiment, the obturator 13900 comprises a pointed, puncture tip 13910. In embodiments in which the trocar 13800 and obturator 13900 are inserted through a gel pad 10530 rather than a body wall, potential damage to underlying tissue by contact with the tip 13910 is reduced because the gel pad 10530 serves as an artificial body wall that is spaced from the underlying tissue as discussed above. In other embodiments, the obturator tip 13910 has another shape, for example, blunt and/or bladeless, which, for example, reduces the likelihood of damage to other components of the access system, for example, a retraction sheath of a retractor.


The trocar 13800 comprises a proximal end, a distal end, and a longitudinal axis. The trocar 13800 comprises a cannula 13810 extending along the longitudinal axis. A trocar seal 13820 is disposed at the proximal end of the cannula 13810. A retainer 13830 is disposed at the distal end or tip of the cannula 13810. In the illustrated embodiment, the distal end or tip of the cannula 13810 is not angled. Other embodiments comprise an angled distal end or tip of the cannula 13810. The illustrated embodiment of the trocar 13800 does not comprise an insufflation gas inlet. Consequently, the trocar 13800 is typically used in procedures in which a body cavity is not insufflated, or in which insufflation is provided through another device. Other embodiments of trocars are disclosed in U.S. patent application Ser. No. 11/677,994, filed Feb. 22, 2007, the disclosure of which is incorporated by reference.


The cannula 13810 comprises an elongate, tubular cannula body 13812 dimensioned to accommodate an instrument or instruments received there through. In the illustrated embodiment, the cannula body 13812 is a substantially cylindrical tube, and extends through the gel pad 10530 in use. In the illustrated embodiment, the cannula body 13812 extends from the proximal end of the cannula 13810 to which the trocar seal 13820 is coupled, and which has a larger outer diameter than the cannula body 13812.


In some embodiments, the cannula 13810 is comparatively short because the cannula body 13812 need only traverse the gel pad 10530 (FIG. 10A), which has a known and consistent thickness, rather than a body wall. Accordingly, some embodiments of the cannula body 13812 are not more than about 2-times longer, about 1.5-times longer, about 1.2-times longer, or about 1.1-times longer than the thickness of the gel pad. In some embodiments, the cannula body 13812 is less than about 20 mm, about 10 mm, or about 5 mm longer than the thickness of the gel pad. In some embodiments, the cannula body 13812 is about as long as the gel pad is thick. In other embodiments, the cannula body 13812 has a different length, for example, a length typical for a cannula used for traversing a body wall. Shorter length cannula bodies permit increased angular degrees of freedom for instruments passing there through. Embodiments of shorter cannula bodies also accommodate curved instruments. The cannula 13810 comprises any suitable biocompatible material. In some embodiments, the cannula 13810 comprises a flexible material.


The illustrated trocar seal 13820 comprises an instrument or septum seal 13822 and a zero seal 13824. The instrument seal 13822 seals instruments passing there through, thereby maintaining pressurization in a body cavity such as pneumoperitoneum or pneumorectum. The zero seal 13824 provides a seal when no instrument passes through the trocar seal 13820. The instrument seal 13822 and zero seal 13824 are received in a housing 13826 disposed at the proximal end of the cannula 13810 and secured therein by a seal cover 13828.


The retainer 13830 is disposed at or near the distal end of the cannula 13810. In the illustrated embodiment, the distal end of the cannula 13810 is generally perpendicular to the longitudinal axis thereof, or not angled. Other embodiments comprise an angled distal end or tip. In some embodiments, the retainer 13830 and cannula 13810 are integrated, while in other embodiments, the retainer 13830 and cannula 13810 are not integrated. In the illustrated embodiment, the proximal end of the retainer 13830 comprises a flange 13832 that is generally flat and perpendicular to the longitudinal axis, while the distal end is tapered, narrowing toward the distal end of the cannula 13810. The flange 13832 reduces the likelihood of accidental or inadvertent removal of the trocar 13800 from the gel pad. Some embodiments of the proximal face of the flange 13832 comprise additional anchoring features, for example, at least one of barbs, spikes, ridges, texturing, and the like, which are configured to penetrate or bite into a distal face of the gel pad 10530. In some embodiments, a diameter of the flange 13832 is from about 1.5 to about 2.5 times wider, or from about 2 to about 2.2 times wider than an outer diameter of the cannula body 13812. Some embodiments of the trocar 13800 are 5-mm trocars, in which the outer diameter of the cannula body 13812 is from about 7 mm to about 8 mm.


The tapered end of the retainer 13830 facilitates insertion of the trocar 13800 through the gel pad, either by itself, or when assembled with the obturator 13900 extending there through. For example, in some embodiments, the retainer 13830 is inserted through a preformed opening in the gel pad 10530. Because embodiments of the gel material of the gel pad 10530 have high elongation values, as discussed above, the retainer 13830 is insertable through a relatively small opening in the gel pad 10530, yet resists inadvertent removal, as discussed above.


In some embodiments in which the retainer 13830 and cannula 13810 are not integrated, that is, are separate components, the retainer 13830 is secured to the cannula 13810 after the cannula 13810 is inserted through the gel pad. In some embodiments, the cannula 13810 and retainer 13830 are secured mechanically, for example, using latches, screw threads, clips, lock rings, ratchets, and the like. In some embodiments, the cannula 13810 and retainer 13830 are secured adhesively. In some embodiments, the position of the retainer 13830 is adjustable, for example, to accommodate gel pads of different thicknesses. In some embodiments, the cannula 13810 and/or retainer 13830 is secured to the gel pad, for example, adhesively.



FIG. 14A is a side view of another embodiment of a trocar 14800 that is suitable as a component of a single-port surgical access system described above, for example, comprising a gel pad 10530 and retractor. Some embodiments of the access system comprise a plurality of trocars 14800. The trocar 14800 is generally similar to the trocar 13800 described above, and comprises a cannula 14810, a trocar seal assembly 14820, and a retainer 14830, which are generally similar to the corresponding features described above. The illustrated embodiment of the trocar 14800 further comprises a bolster 14840 and a locking component 14850. The illustrated embodiment of the cannula 14810 is also referred to as a “fixation cannula” as will become apparent from the discussion below.


In the illustrated embodiment, the bolster 14840 comprises a torus or doughnut. A cannula body 14812 extends through an opening in the bolster 14840. A diameter of the opening of the bolster 14840 is sufficiently larger than an outer diameter of the cannula body 14812 to permit free movement along the cannula body 14812. The illustrated embodiment of the bolster 14840 comprises a deformable material, for example, a polymer resin and/or elastomer, as will be described in greater detail below. Examples of suitable materials include rubber, natural rubber, synthetic rubber, polyisoprene, styrene-butadiene rubber, silicone rubber, ethylene-propylene copolymer, ethylene-propylene-diene monomer rubber, polybutadiene, polychloroprene, polyurethane, and the like. Some embodiments of the bolster 14840 comprise a lubricious layer or coating in an area or region that contacts the cannula 14810, which facilitates movement along the cannula 14810.


An outer diameter of some embodiments of the bolster 14840 is from about 0.8 to about 2 times, or from about 1 to about 1.5 times a diameter of a flange 14832 of the retainer 14830. A thickness of the bolster is from about 3 mm (0.12 inch) to about 10 mm (0.4 inch), or from about 4 mm (0.16 inch) to about 6 mm (0.24 inch). In some embodiments, a distal face 14844 of the bolster is concave, thereby providing additional clamping or fixation force on the gel pad 10530, as well as conforming to gel pads 10530 with different and/or non-uniform thicknesses. The particular dimensions of the bolster 14830 are selected based on the properties of the bolster material and the gel material, and the dimensions of the cannula body 14812, the locking component 14850, and the gel pad 10530.


The locking component 14850 is disposed on the cannula body 14812 proximal of the retainer 14830, and comprises a lip 14852 proximal of an enlarged section 14854. The lip 14852 extends radially from the cannula body 14812 with a diameter greater than the diameter of the opening of the bolster 14840. The elastomeric material of the bolster 14840 permits the bolster 14840 to be urged over and past the lip 14852. In the illustrated embodiment, the lip 14852 comprises a ratchet dimensioned to facilitate the bolster 14840 sliding distally and to resist the bolster 14840 from sliding proximally. Also, in the illustrated embodiment, the lip 14852 is a continuous structure encircling the cannula body 14812. In other embodiments, the lip 14852 comprises a plurality of structures disposed around the cannula body 14812.


The enlarged section 14854 is generally cylindrical with a diameter that is about the same as or slightly larger than the diameter of the opening in the bolster 14840, thereby frictionally engaging the bolster 14840 thereto. In the illustrated embodiment, the enlarged section 14854 is longer than a thickness of the bolster 14840. In the illustrated embodiment, the enlarged section 14854 does not extend to or contact the flange 14832 of the retainer 14830, thereby not reducing a surface area of a proximal face thereof, and thereby improving the removal resistance thereof. In other embodiments, the enlarged section 14854 extends to the retainer 14830. Other embodiments do not comprise an enlarged section.


A distance between a distal end of the lip 14852 and a proximal face of the flange 14832 is equal to or slightly less than a sum of a thickness of the bolster 14840 and the gel pad 10530. In some embodiments, the gel pad is from about 5 mm (about 0.4 inch) to about 30 mm (about 1.2 inch) thick, or from about 13 mm (about 0.5 inch) to about 25 mm (about 1 inch) thick.


The trocar 14800 has at least two configurations: a first or insertion configuration illustrated in FIG. 14A, and a second or fixation configuration illustrated in FIG. 14B.


In an embodiment of a method for using the trocar 14800, the trocar 14800 is placed in the insertion configuration in which the bolster 14840 is first positioned on the cannula body 14812. The trocar 14800 is placed in the artificial body wall either before the artificial body wall is coupled to a patient's body and/or after coupling thereto.


In the embodiment illustrated in FIG. 14A, the bolster 14840 is positioned at the proximal end of the cannula body 14812, where the bolster 14840 frictionally engages a distal portion of a cannula bell 14814, which is an enlarged portion at the proximal end of the cannula 14810 to which the seal assembly 14820 couples.


The distal end of the trocar 14800 is positioned on, then the retainer 14830 inserted through an artificial body wall, for example, a gel pad 10530. In some embodiments, an obturator 13900 (FIG. 13) is first inserted through the seal assembly 14820 at the proximal end of the trocar with the tip 13910 extending from the distal end thereof before this step. In other embodiments, an opening is first made in the artificial body wall using another instrument. In other embodiments, the distal end of the trocar 14800 is forced through the artificial body wall, generating an opening in the process.


The trocar 14800 is then converted into the fixation configuration illustrated in FIG. 14B by sliding the bolster 14840 down the cannula body 14812, and over the lip 14852 onto the enlarged section 14852. In the illustrated configuration, the artificial body wall is captured and compressed between the flange 14830 of the retainer and the bolster 14840. The lip 14852 locks the bolster 14840 in place, preventing it from moving proximally, thereby fixing or locking the trocar 14800 to the artificial body wall.


In the fixation configuration, the trocar 14800 fixed relative to a local portion of the artificial body wall to which it is engaged. As discussed above, however, embodiments of artificial body walls exhibit high elongations. Accordingly, the trocar 14800 is translatable and/or pivotable relative to an original position and orientation by deforming the artificial body wall.


In embodiments using an obturator 13910, the obturator is withdrawn. The trocar 14800 serves as an access port for one or more instruments during a surgical procedure.


If desired, the trocar 14800 is removed from the artificial body wall, for example, by first disengaging the bolster 14840 from the locking component 14850, then pulling the retainer 14830 from the artificial body wall. In some embodiments, the trocar 14800 and artificial body wall are not disengaged and are disposed of as a unit. In some embodiments, the bolster 14840 is not disengagable from the locking component 14850.



FIG. 15 is a side view of another embodiment of a retention trocar 15000, which is generally similar to the embodiment illustrated in FIGS. 14A and 14B and described above. The trocar 15000 comprises an elongate, tubular cannula 15810 comprising a proximal end, a distal end, and a cannula body 15812; a seal assembly 15820 coupled to the proximal end of the cannula 15810; a retainer 15830 disposed at the distal end of the cannula 15810; a bolster 14840 through which the cannula body 15812 extends; and a locking component 15850 disposed on the cannula body proximal of the retainer 15830.


In the illustrated embodiment, the locking component 15850 comprises an enlarged section 15854 on which are disposed screw threads 15852. The bolster 15840 comprises matching threads. Consequently, the bolster 15840 is threadably engagable to the locking component 15850. The threading also permits adjusting the relative positions of the bolster 15840 and a flange 15832 of the retainer in the fixation configuration of the trocar 15800, thereby permitting fixation to an artificial body wall with a non-uniform thickness and/or to artificial body walls of different thicknesses.



FIG. 16A is a side view of another embodiment of a trocar 16800. FIG. 16B is a perspective view of an embodiment of a bolster 16840 usable with the trocar 16800. The combination of the trocar 16800 and bolster 16840 are generally similar to the embodiments of trocars illustrated in FIGS. 14A, 14B, and 15. The trocar 16800 comprises an elongate, tubular fixation cannula 16810 comprising a proximal end, a distal end, and a cannula body 16812; a seal assembly 16820 coupled to the proximal end of the cannula 16810; a retainer 16830 disposed at the distal end of the cannula 16810; and a locking component 16850 disposed on the cannula body proximal of the retainer 16830.


In the illustrated embodiment, the locking component 16850 comprises an enlarged section 16854 comprising a plurality of annular rings 16852 extending radially from the cannula body 16812, which define a plurality of annular slots 16856. In the illustrated embodiment, a proximal edge of each ring 16856 is beveled; however, some embodiments do not comprise a beveled edge.



FIG. 16B illustrates an embodiment of a bolster 16840 in the form of a clip comprising a flattened body 16842 comprising a cut-out 16844 comprising a semicircular portion. The cut-out 16844 is dimensioned to engage the slots 16856. A thickness of the body 16842 at the cut-out 16844 is also dimensioned to engage the slots 16856. The bolster 16840 comprises a grip 16846 extending vertically from the body 16842, which provides a user grip for installing and/or adjusting the bolster 16840. In other embodiments, the cut-out 16844 has another shape, for example, polygonal, rectangular, a portion of a hexagon, and the like.


In use, the retainer 16830 of the trocar is inserted through an artificial body wall as discussed above, and fixed therein by engaging the bolster 16840 in a slot 16856 providing a desired fixation force. The degree of fixation is adjustable by selecting a different slot.


In some embodiments, the bolster cut-out 16844 engages a plurality of slots, thereby providing additional stability in the fixation configuration. Other embodiments comprise a bolster through with the cannula body 16812 extends, similar to the embodiments discussed above. In some of these embodiments, the locking component 16850 serves as a ratchet. The bolster comprises one or more pawls, which are optionally disengagable, thereby enhancing adjustability.



FIG. 17A illustrates a side view of an embodiment of a trocar 17800 comprising a fixation cannula and FIG. 17B is a perspective view of an embodiment of a bolster. The embodiments illustrated in FIGS. 17A and 17B are generally similar to the embodiments of trocars illustrated in FIGS. 14A-16B and described above.


The trocar 17800 comprises an elongate, tubular fixation cannula 17810 comprising a proximal end, a distal end, and a cannula body 17812; a seal assembly 17820 coupled to the proximal end of the cannula 17810; a retainer 17830 disposed on the cannula body 17812; and a locking component 17850 disposed at the distal end of the cannula 17810. The illustrated embodiment of the trocar 17800 is similar to the embodiment illustrated in FIG. 16A with the positions of the retainer 17830 and the locking component 17850 reversed. In the illustrated embodiment, a flange 17832 of the retainer faces distally.


The locking component 17850 comprises an enlarged section 17854 comprising a plurality of annular rings 17852 extending radially from the cannula body 17812, which define a plurality of annular slots 17856.



FIG. 17B illustrates an embodiment of a bolster 17840 in the form of a clip comprising a flattened body 17842 comprising a cut-out 17844 comprising a semicircular portion. The cut-out 17844 is dimensioned to engage slots 17856 in the locking component. A thickness of the body 17842 at the cut-out 17844 is also dimensioned to engage the slots 17856. The illustrated embodiment of the bolster does not comprise a grip; however, other embodiments comprise a grip.


In some embodiments for using the embodiment of the trocar 17800, the cannula 17810 is fixed to an artificial body wall before the artificial body wall is coupled to a patient's body. For example, in some embodiments, one or more trocars 17800 are fixed on a gel pad 10530 (FIG. 10A) of a gel cap 10500 before the gel cap 10500 is coupled to a retractor 6100.


While certain embodiments have been particularly shown and described with reference to exemplary embodiments thereof, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope thereof as defined by the following claims.

Claims
  • 1. A surgical access port system adapted for performing surgical procedures at a natural orifice comprising: an outer ring, wherein the outer ring is configured to be disposed proximate the natural orifice of a patient;a tubular body having a longitudinal axis, a proximal end and a distal end, wherein the proximal end of the tubular body is coupled to the outer ring; andan inflatable saddle-shaped balloon disposed around the distal end of the tubular body, the saddle-shaped balloon comprising a first peak and a second peak, the second peak displaced from the first peak along the longitudinal axis of the tubular body, wherein the saddle-shaped balloon is adapted to compress a tissue of the natural orifice between the first peak and the second peak upon inflation to thereby occlude the natural orifice, and wherein the tubular body and the inflatable saddle-shaped balloon are of a unitary one-piece construction.
  • 2. The surgical access port system of claim 1, wherein the proximal end of the tubular body comprises a funnel segment.
  • 3. The surgical access port system of claim 1, wherein the inflatable saddle-shaped balloon has a diameter between 2 inches and 4 inches.
  • 4. The surgical access port system of claim 1 further comprising an inflation port located near the proximal end of the tubular body, the inflation port configured to inflate the inflatable saddle-shaped balloon.
  • 5. The surgical access port system of claim 4, wherein the inflation port is configured to allow gas to inflate the inflatable saddle-shaped balloon.
  • 6. The surgical access port system of claim 4, wherein the inflation port is configured to allow liquid to inflate the inflatable saddle-shaped balloon.
  • 7. The surgical access port system of claim 1, wherein a low point of the inflatable saddle-shaped balloon between the first peak and the second peak is configured to compress the tissue of the natural orifice therebetween.
  • 8. The surgical access port system of claim 1 further comprising suture ties configured to further prevent dislodging of the surgical access port system from the natural orifice.
  • 9. The surgical access port system of claim 1, wherein the inflatable saddle-shaped balloon is formed by heat-shrinking tubing around the distal end of the tubular body.
  • 10. The surgical access port system of claim 1, wherein the inflatable saddle-shaped balloon tapers from a first larger diameter to a smaller second diameter, and wherein the tapering is of a constant rate.
  • 11. The surgical access port system of claim 10, wherein the inflatable saddle-shaped balloon tapers from a diameter of 4 inches to 2 inches.
  • 12. A surgical access port system adapted for performing surgical procedures at a natural orifice comprising: an outer ring, wherein the outer ring is configured to be disposed proximate the natural orifice of a patient;a tubular body having a longitudinal axis, a proximal end, and a distal end, wherein the proximal end of the tubular body is coupled to the outer ring; andan inflatable balloon disposed around the distal end of the tubular body, the inflatable balloon having at least two peaks that are displaced from each other, wherein the inflatable balloon is configured to compress tissue of the natural orifice between the at least two peaks thereby occluding the natural orifice, and wherein the tubular body and the inflatable balloon are of a unitary one-piece construction.
  • 13. The surgical access port system of claim 12 further comprising an inflation port located near the proximal end of the tubular body, the inflation port configured to inflate the inflatable balloon.
  • 14. The surgical access port system of claim 13, wherein the inflation port is configured to allow gas to inflate the inflatable balloon.
  • 15. The surgical access port system of claim 13, wherein the inflation port is configured to allow liquid to inflate the inflatable balloon.
  • 16. The surgical access port system of claim 12, wherein a low point of the inflatable balloon between adjacent peaks is configured to compress the tissue of the natural orifice therebetween.
  • 17. The surgical access port system of claim 12 further comprising suture ties configured to further prevent dislodging of the surgical access port system from the natural orifice.
  • 18. A surgical access port system adapted for performing surgical procedures at a natural orifice comprising: an outer ring, wherein the outer ring is configured to be disposed proximate the natural orifice of a patient;a tubular body having a longitudinal axis, a proximal end and a distal end, wherein the proximal end of the tubular body is coupled to the outer ring; andan inflatable saddle-shaped balloon disposed around the distal end of the tubular body, the saddle-shaped balloon comprising a first peak and a second peak, the second peak displaced from the first peak along the longitudinal axis of the tubular body, wherein the saddle-shaped balloon is adapted to compress a tissue of the natural orifice between the first peak and the second peak upon inflation to thereby occlude the natural orifice, and wherein the inflatable saddle-shaped balloon tapers from a first larger diameter to a second smaller diameter, wherein the tapering of the inflatable saddle-shaped balloon from the first larger diameter to the second smaller diameter is constant.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/826,336 filed Aug. 14, 2015 entitled “Natural orifice surgery system,” which claims the benefit of U.S. Provisional Patent Application Ser. No. 62/038,082, filed Aug. 15, 2014 entitled “Natural orifice surgery system,” the entire disclosures of which are incorporated by reference.

US Referenced Citations (940)
Number Name Date Kind
52014 Barlett Jan 1866 A
202813 Hall Apr 1878 A
447761 Clough Mar 1891 A
558364 Doolittle Apr 1896 A
758535 Howden Apr 1904 A
929583 Gibbs Jul 1909 A
1056966 Belding Mar 1913 A
1157202 Bates et al. Oct 1915 A
1221123 Westhaver Apr 1917 A
1242972 Petit Oct 1917 A
1598284 Kinney Aug 1926 A
1690995 Pratt Nov 1928 A
1180466 Deutsch Jun 1931 A
1810466 Deutsch Jun 1931 A
2219564 Reyniers Oct 1940 A
2305289 Coburg Dec 1942 A
2313164 Nelson Mar 1943 A
2478586 Krapp Aug 1949 A
2669991 Curutchet Feb 1954 A
2695608 Gibbon Nov 1954 A
2812758 Blumenschein Nov 1957 A
2835253 Borgeson May 1958 A
2853075 Hoffman et al. Sep 1958 A
3039468 Price Jun 1962 A
3057350 Cowley Oct 1962 A
3108595 Overment Oct 1963 A
3111943 Orndorff Nov 1963 A
3129706 Reynolds, Jr. Apr 1964 A
3195934 Parrish Jul 1965 A
3244169 Baxter Apr 1966 A
3253594 Matthews et al. May 1966 A
3313299 Spademan Apr 1967 A
3329390 Hulsey Jul 1967 A
3332417 Blanford et al. Jul 1967 A
3347226 Harrower Oct 1967 A
3347227 Harrower Oct 1967 A
3397692 Creager, Jr. et al. Aug 1968 A
3402710 Paleschuck Sep 1968 A
3416520 Creager, Jr. Dec 1968 A
3447533 Spicer Jun 1969 A
3522800 Lesser Aug 1970 A
3523534 Nolan Aug 1970 A
3553862 Hamu Jan 1971 A
3570475 Weinstein Mar 1971 A
3656485 Robertson Apr 1972 A
3685786 Woodson Aug 1972 A
3703896 Nuwayser Nov 1972 A
3717151 Collett Feb 1973 A
3717883 Mosher Feb 1973 A
3729006 Wilder et al. Apr 1973 A
3729027 Bare Apr 1973 A
3762080 Poole Oct 1973 A
3774596 Cook Nov 1973 A
3782370 McDonald Jan 1974 A
3788318 Kim et al. Jan 1974 A
3789852 Kim et al. Feb 1974 A
3797478 Walsh et al. Mar 1974 A
3799166 Marsan Mar 1974 A
3807393 McDonald Apr 1974 A
3828764 Jones Aug 1974 A
3831583 Edmunds et al. Aug 1974 A
3841332 Treacle Oct 1974 A
3850172 Cazalis Nov 1974 A
3853126 Schulte Dec 1974 A
3853127 Spademan Dec 1974 A
3856021 McIntosh Dec 1974 A
3860274 Ledstrom et al. Jan 1975 A
3861416 Wichterle Jan 1975 A
3863639 Kleaveland Feb 1975 A
3907389 Cox et al. Sep 1975 A
3915171 Shermeta Oct 1975 A
3965890 Gauthier Jun 1976 A
3970089 Saice Jul 1976 A
3996623 Kaster Dec 1976 A
4000739 Stevens Jan 1977 A
4016884 Kwan-Gett Apr 1977 A
4024872 Muldoon May 1977 A
4030500 Ronnquist Jun 1977 A
4043328 Cawood, Jr. et al. Aug 1977 A
4069913 Harrigan Jan 1978 A
4082005 Erdley Apr 1978 A
4083370 Taylor Apr 1978 A
4096853 Weigand Jun 1978 A
4112932 Chiulli Sep 1978 A
4117847 Clayton Oct 1978 A
4130113 Graham Dec 1978 A
4141364 Schultze Feb 1979 A
4177814 Knepshield et al. Dec 1979 A
4183357 Bentley et al. Jan 1980 A
4187849 Stim Feb 1980 A
4188945 Wenander Feb 1980 A
4189880 Ballin Feb 1980 A
4217664 Faso Aug 1980 A
4222126 Boretos et al. Sep 1980 A
4228792 Rhys-Davies Oct 1980 A
4239036 Krieger Dec 1980 A
4240411 Hosono Dec 1980 A
4253201 Ross et al. Mar 1981 A
4254973 Banjamin Mar 1981 A
4306562 Osborne Dec 1981 A
4321915 Leighton Mar 1982 A
4331138 Jessen May 1982 A
4338934 Spademan Jul 1982 A
4338937 Lerman Jul 1982 A
4367728 Mutke Jan 1983 A
4369284 Chen Jan 1983 A
4399816 Spangler Aug 1983 A
4402683 Kopman Sep 1983 A
4411659 Jensen et al. Oct 1983 A
4421296 Stephens Dec 1983 A
4424833 Spector et al. Jan 1984 A
4428364 Bartolo Jan 1984 A
4430081 Timmermans Feb 1984 A
4434791 Darnell Mar 1984 A
4436519 O'Neill Mar 1984 A
4454873 Laufenberg et al. Jun 1984 A
4473067 Schiff Sep 1984 A
4475548 Muto Oct 1984 A
4485490 Akers et al. Dec 1984 A
4488877 Klein Dec 1984 A
4508355 Ditcher Apr 1985 A
4543088 Bootman et al. Sep 1985 A
4550713 Hyman Nov 1985 A
4553537 Rosenberg Nov 1985 A
4555242 Saudagar Nov 1985 A
4556996 Wallace Dec 1985 A
4601710 Moll Jul 1986 A
4610665 Matsumoto et al. Sep 1986 A
4626245 Weinstein Dec 1986 A
4634424 O'Boyle Jan 1987 A
4634432 Kocak Jan 1987 A
4644951 Bays Feb 1987 A
4649904 Krauter Mar 1987 A
4653476 Bonnet Mar 1987 A
4654030 Moll et al. Mar 1987 A
4655752 Honkanen et al. Apr 1987 A
4673393 Suzuki et al. Jun 1987 A
4673394 Fenton Jun 1987 A
4691942 Ford Sep 1987 A
4714749 Hughes et al. Dec 1987 A
4738666 Fuqua Apr 1988 A
4755170 Golden Jul 1988 A
4760933 Christner et al. Aug 1988 A
4776843 Martinez et al. Oct 1988 A
4777943 Chvapil Oct 1988 A
4784646 Feingold Nov 1988 A
4796629 Grayzel Jan 1989 A
4798594 Hillstead Jan 1989 A
4802694 Vargo Feb 1989 A
4808168 Warring Feb 1989 A
4809679 Shimonaka et al. Mar 1989 A
4828554 Griffin May 1989 A
4842931 Zook Jun 1989 A
4848575 Nakamura et al. Jul 1989 A
4856502 Ersfeld et al. Aug 1989 A
4863430 Klyce et al. Sep 1989 A
4863438 Gauderer et al. Sep 1989 A
4889107 Kaufman Dec 1989 A
4895565 Hillstead Jan 1990 A
4897081 Poirier Jan 1990 A
4903710 Jessamine et al. Feb 1990 A
4911974 Shimizu et al. Mar 1990 A
4915132 Hodge et al. Apr 1990 A
4926882 Lawrence May 1990 A
4929235 Merry et al. May 1990 A
4944732 Russo Jul 1990 A
4950222 Scott et al. Aug 1990 A
4950223 Silvanov Aug 1990 A
4984564 Yuen Jan 1991 A
4991593 LeVahn Feb 1991 A
4998538 Charowsky et al. Mar 1991 A
5000745 Guest et al. Mar 1991 A
5009224 Cole Apr 1991 A
5015228 Columbus et al. May 1991 A
5019101 Purkait et al. May 1991 A
5026366 Leckrone Jun 1991 A
5037379 Clayman et al. Aug 1991 A
5041095 Littrell Aug 1991 A
5045070 Grodecki et al. Sep 1991 A
D320658 Quigley et al. Oct 1991 S
5053009 Herzberg Oct 1991 A
5071411 Hillstead Dec 1991 A
5073169 Raiken Dec 1991 A
5074878 Bark et al. Dec 1991 A
5082005 Kaldany Jan 1992 A
5086763 Hathman Feb 1992 A
5092846 Nishijima et al. Mar 1992 A
5104389 Deem Apr 1992 A
5108420 Marks Apr 1992 A
5125396 Ray Jun 1992 A
5125897 Quinn et al. Jun 1992 A
5127626 Hilal et al. Jul 1992 A
5129885 Green et al. Jul 1992 A
5141498 Christian Aug 1992 A
5149327 Oshiyama Sep 1992 A
5156617 Reid Oct 1992 A
5158553 Berry et al. Oct 1992 A
5159921 Hoover Nov 1992 A
5161773 Tower Nov 1992 A
5167636 Clement Dec 1992 A
5167637 Okada et al. Dec 1992 A
5171223 Herzberg Dec 1992 A
5176648 Holmes et al. Jan 1993 A
5176662 Bartholomew et al. Jan 1993 A
5176697 Hasson et al. Jan 1993 A
5178162 Bose Jan 1993 A
5180365 Ensminger et al. Jan 1993 A
5183471 Wilk Feb 1993 A
5188595 Jacobi Feb 1993 A
5188607 Wu Feb 1993 A
5192301 Kamiya et al. Mar 1993 A
5197955 Stephens et al. Mar 1993 A
5197971 Bonutti Mar 1993 A
5207656 Kranys May 1993 A
5209737 Rirchart et al. May 1993 A
5211370 Powers May 1993 A
5211633 Stouder, Jr. May 1993 A
5213114 Bailey, Jr. May 1993 A
5226890 Ianniruberto et al. Jul 1993 A
5234455 Mulhollan Aug 1993 A
5241968 Slater Sep 1993 A
5242400 Blake, III et al. Sep 1993 A
5242409 Buelna Sep 1993 A
5242412 Blake, III et al. Sep 1993 A
5242415 Kantrowitz et al. Sep 1993 A
5248304 Vigdorchik et al. Sep 1993 A
5256150 Quiachon et al. Oct 1993 A
5257973 Villasuso Nov 1993 A
5257975 Foshee Nov 1993 A
5259366 Reydel et al. Nov 1993 A
5261883 Hood et al. Nov 1993 A
5262468 Chen Nov 1993 A
5263922 Sova et al. Nov 1993 A
5269763 Boehmer et al. Dec 1993 A
5269772 Wilk Dec 1993 A
5273449 Mattis et al. Dec 1993 A
5273545 Hunt et al. Dec 1993 A
D343236 Quigley et al. Jan 1994 S
5279575 Sugarbaker Jan 1994 A
5290310 Makower et al. Mar 1994 A
D346022 Quigley et al. Apr 1994 S
5299582 Potts Apr 1994 A
5300034 Behnke Apr 1994 A
5300035 Clement Apr 1994 A
5300036 Mueller et al. Apr 1994 A
5303486 Dell Apr 1994 A
5308336 Hart et al. May 1994 A
5309896 Moll et al. May 1994 A
5312391 Wilk May 1994 A
5314417 Stephens et al. May 1994 A
5316541 Fischer May 1994 A
5320611 Bonutti et al. Jun 1994 A
5330437 Durman Jul 1994 A
5330486 Wilk Jul 1994 A
5330497 Freitas et al. Jul 1994 A
5331975 Bonutti Jul 1994 A
5334143 Carroll Aug 1994 A
5334646 Chen Aug 1994 A
5336192 Palestrant Aug 1994 A
5336708 Chen Aug 1994 A
5338313 Mollenauer et al. Aug 1994 A
5342315 Rowe et al. Aug 1994 A
5342385 Norelli et al. Aug 1994 A
5345927 Bonutti Sep 1994 A
5350364 Stephens et al. Sep 1994 A
5353786 Wilk Oct 1994 A
5354280 Haber et al. Oct 1994 A
5360417 Gravener et al. Nov 1994 A
5364345 Lowery et al. Nov 1994 A
5364372 Danks et al. Nov 1994 A
5366446 Tal et al. Nov 1994 A
5366473 Winston et al. Nov 1994 A
5366478 Brinkerhoff Nov 1994 A
5368545 Schaller et al. Nov 1994 A
5375588 Yoon Dec 1994 A
5380288 Hart et al. Jan 1995 A
5383861 Hempel et al. Jan 1995 A
5385552 Haber et al. Jan 1995 A
5385553 Hart et al. Jan 1995 A
5385560 Wulf Jan 1995 A
5389080 Yoon Feb 1995 A
5389081 Castro Feb 1995 A
5391153 Haber et al. Feb 1995 A
5391156 Hildwein et al. Feb 1995 A
5395367 Wilk Mar 1995 A
5403264 Wohlers et al. Apr 1995 A
5403336 Kieturakis et al. Apr 1995 A
5407433 Loomas Apr 1995 A
5411483 Loomas May 1995 A
5413571 Katsaros et al. May 1995 A
5423848 Washizuka et al. Jun 1995 A
5429609 Yoon Jul 1995 A
5431676 Durdal et al. Jul 1995 A
5437683 Neumann et al. Aug 1995 A
5439455 Kieturakis et al. Aug 1995 A
5441486 Yoon Aug 1995 A
5443452 Hart et al. Aug 1995 A
5454365 Bonutti Oct 1995 A
5456284 Ryan et al. Oct 1995 A
5460170 Hammerslag Oct 1995 A
5460616 Weinstein et al. Oct 1995 A
5468248 Chin et al. Nov 1995 A
5476475 Gadberry Dec 1995 A
5480410 Cuschieri et al. Jan 1996 A
5486426 McGee et al. Jan 1996 A
5490843 Hildwein et al. Feb 1996 A
5492304 Smith et al. Feb 1996 A
5496280 Vandenbroek et al. Mar 1996 A
5503112 Luhman et al. Apr 1996 A
5507758 Thomason et al. Apr 1996 A
5508334 Chen Apr 1996 A
5511564 Wilk Apr 1996 A
5514109 Mollenauer et al. May 1996 A
5514133 Golub et al. May 1996 A
5514153 Bonutti May 1996 A
5518278 Sampson May 1996 A
5520632 Leveen May 1996 A
5522791 Leyva Jun 1996 A
5522824 Ashby Jun 1996 A
5524644 Crook Jun 1996 A
5526536 Cartmill Jun 1996 A
5531758 Uschold et al. Jul 1996 A
5538509 Dunlap et al. Jul 1996 A
5540648 Yoon Jul 1996 A
5540658 Evans Jul 1996 A
5540711 Kieturakis et al. Jul 1996 A
5545150 Danks et al. Aug 1996 A
5545179 Williamson, IV Aug 1996 A
5549563 Kronner Aug 1996 A
5549637 Crainich Aug 1996 A
5554124 Alvarado Sep 1996 A
5555653 Morgan Sep 1996 A
5562632 Davila et al. Oct 1996 A
5562677 Hildwein et al. Oct 1996 A
5562688 Riza Oct 1996 A
5571115 Nicholas Nov 1996 A
5571137 Marlow et al. Nov 1996 A
5575799 Bolanos et al. Nov 1996 A
5577993 Zhu et al. Nov 1996 A
5578048 Pasqualucci et al. Nov 1996 A
5580344 Hasson Dec 1996 A
5584850 Hart et al. Dec 1996 A
5601579 Semertzides Feb 1997 A
5601581 Fogarty et al. Feb 1997 A
5603702 Smith et al. Feb 1997 A
5607443 Kieturakis et al. Mar 1997 A
5620415 Lucey et al. Apr 1997 A
5620420 Kriesel Apr 1997 A
5628732 Antoon, Jr. et al. May 1997 A
5632284 Graether May 1997 A
5632979 Goldberg et al. May 1997 A
5634911 Hermann et al. Jun 1997 A
5634936 Linden et al. Jun 1997 A
5634937 Mollenauer et al. Jun 1997 A
5636645 Ou Jun 1997 A
5640977 Leahy et al. Jun 1997 A
5643301 Mollenauer Jul 1997 A
5649550 Crook Jul 1997 A
5651771 Tangherlini et al. Jul 1997 A
5653705 de la Torre et al. Aug 1997 A
5657963 Hinchliffe et al. Aug 1997 A
5658272 Hasson Aug 1997 A
5658306 Kieturakis Aug 1997 A
5662615 Blake, III Sep 1997 A
5672168 de la Torre et al. Sep 1997 A
5681341 Lunsford et al. Oct 1997 A
5683378 Christy Nov 1997 A
5685854 Green et al. Nov 1997 A
5685857 Negus et al. Nov 1997 A
5697914 Brimhall Dec 1997 A
5707703 Rothrum et al. Jan 1998 A
5709664 Vandenbroek et al. Jan 1998 A
5713858 Heruth et al. Feb 1998 A
5713869 Morejon Feb 1998 A
5720730 Blake, III Feb 1998 A
5725536 Oberlin et al. Mar 1998 A
5728103 Picha et al. Mar 1998 A
5730748 Fogarty et al. Mar 1998 A
5735791 Alexander et al. Apr 1998 A
5738628 Sierocuk et al. Apr 1998 A
5741234 Aboul-Hosn Apr 1998 A
5741298 MacLeod Apr 1998 A
5743884 Hasson et al. Apr 1998 A
5749882 Hart et al. May 1998 A
5753150 Martin et al. May 1998 A
5755660 Tyagi May 1998 A
5760117 Chen Jun 1998 A
5769783 Fowler Jun 1998 A
5782812 Hart et al. Jul 1998 A
5782817 Franzel et al. Jul 1998 A
5782859 Nicholas et al. Jul 1998 A
5788676 Yoon Aug 1998 A
5792119 Marx Aug 1998 A
5794528 Gronig et al. Aug 1998 A
5795290 Bridges Aug 1998 A
5803919 Hart et al. Sep 1998 A
5803921 Bonadio Sep 1998 A
5803923 Singh-Derewa et al. Sep 1998 A
5807350 Diaz Sep 1998 A
5810712 Dunn Sep 1998 A
5810721 Mueller et al. Sep 1998 A
5813409 Leahy et al. Sep 1998 A
5814026 Yoon Sep 1998 A
5817062 Flom et al. Oct 1998 A
5819375 Kastner Oct 1998 A
5820555 Watkins, III et al. Oct 1998 A
5820600 Carlson et al. Oct 1998 A
5830191 Hildwein et al. Nov 1998 A
5832925 Rothrum Nov 1998 A
5836871 Wallace et al. Nov 1998 A
5836913 Orth Nov 1998 A
5841298 Huang Nov 1998 A
5842971 Yoon Dec 1998 A
5848992 Hart et al. Dec 1998 A
5853395 Crook et al. Dec 1998 A
5853417 Fogarty et al. Dec 1998 A
5857461 Levitsky et al. Jan 1999 A
5860995 Berkelaar Jan 1999 A
5865728 Moll et al. Feb 1999 A
5865729 Meehan et al. Feb 1999 A
5865807 Blake, III Feb 1999 A
5865817 Moenning et al. Feb 1999 A
5871474 Hermann et al. Feb 1999 A
5876413 Fogarty et al. Mar 1999 A
5879368 Hoskin et al. Mar 1999 A
5882344 Strouder, Jr. Mar 1999 A
5884639 Chen Mar 1999 A
5894843 Benetti et al. Apr 1999 A
5895377 Smith et al. Apr 1999 A
5899208 Bonadio May 1999 A
5899913 Fogarty et al. May 1999 A
5904703 Gilson May 1999 A
5906577 Beane et al. May 1999 A
5913847 Yoon Jun 1999 A
5916198 Dillow Jun 1999 A
5916232 Hart Jun 1999 A
5919476 Fischer et al. Jul 1999 A
5931832 Jensen Aug 1999 A
5947922 MacLeod Sep 1999 A
5951467 Picha et al. Sep 1999 A
5951588 Moenning Sep 1999 A
5957888 Hinchiffe et al. Sep 1999 A
5957913 de la Torre et al. Sep 1999 A
5961539 Northrup, III et al. Oct 1999 A
5962572 Chen Oct 1999 A
5964781 Mollenauer et al. Oct 1999 A
5976174 Ruiz Nov 1999 A
5989232 Yoon Nov 1999 A
5989233 Yoon Nov 1999 A
5989266 Foster Nov 1999 A
5993471 Riza et al. Nov 1999 A
5993485 Beckers Nov 1999 A
5993839 Mixon Nov 1999 A
5994450 Pearce Nov 1999 A
5997515 de la Torre et al. Dec 1999 A
6004303 Peterson Dec 1999 A
6010494 Schafer et al. Jan 2000 A
6017355 Hessel et al. Jan 2000 A
6018094 Fox Jan 2000 A
6024736 de la Torre et al. Feb 2000 A
6025067 Fay Feb 2000 A
6030406 Davis Feb 2000 A
6033426 Kaji Mar 2000 A
6033428 Sardella Mar 2000 A
6035559 Freed et al. Mar 2000 A
6042573 Lucey Mar 2000 A
6045535 Ben Nun Apr 2000 A
6048309 Flom et al. Apr 2000 A
6050871 Chen Apr 2000 A
6053934 Andrews et al. Apr 2000 A
6059816 Moenning May 2000 A
6066117 Fox et al. May 2000 A
6068639 Fogarty et al. May 2000 A
6076560 Stahle et al. Jun 2000 A
6077288 Shimomura Jun 2000 A
6086603 Termin et al. Jul 2000 A
6090043 Austin et al. Jul 2000 A
6099506 Macoviak et al. Aug 2000 A
6110154 Shimomura et al. Aug 2000 A
6123689 To et al. Sep 2000 A
6142935 Flom et al. Nov 2000 A
6142936 Beane et al. Nov 2000 A
6149642 Gerhart et al. Nov 2000 A
6150608 Wambeke et al. Nov 2000 A
6154991 Duncan et al. Dec 2000 A
6159182 Davis Dec 2000 A
6162172 Cosgrove et al. Dec 2000 A
6162196 Hart et al. Dec 2000 A
6162206 Bindokas Dec 2000 A
6163949 Neuenschwander Dec 2000 A
6164279 Tweedle Dec 2000 A
6171282 Ragsdale Jan 2001 B1
6183486 Snow et al. Feb 2001 B1
6197002 Peterson Mar 2001 B1
6217555 Hart et al. Apr 2001 B1
6217590 Levinson Apr 2001 B1
6224612 Bates et al. May 2001 B1
6228063 Aboul-Hosn May 2001 B1
6238373 de la Torre et al. May 2001 B1
6241768 Agarwal et al. Jun 2001 B1
6254533 Fadem et al. Jul 2001 B1
6254534 Butler et al. Jul 2001 B1
6258065 Dennis et al. Jul 2001 B1
6264604 Kieturakis et al. Jul 2001 B1
6267751 Mangosong Jul 2001 B1
6276661 Laird Aug 2001 B1
6287280 Lampropoulos et al. Sep 2001 B1
6315770 de la Torre et al. Nov 2001 B1
6319246 de la Torre et al. Nov 2001 B1
6322541 West Nov 2001 B2
6325384 Berry, Sr. et al. Dec 2001 B1
6346074 Roth Feb 2002 B1
6355052 Neuss et al. Mar 2002 B1
6358266 Bonutti Mar 2002 B1
6371968 Kogasaka et al. Apr 2002 B1
6378944 Weisser Apr 2002 B1
6382211 Crook May 2002 B1
6383162 Sugarbaker May 2002 B1
6391043 Moll et al. May 2002 B1
6413244 Bestetti et al. Jul 2002 B1
6413458 Pearce Jul 2002 B1
6420475 Chen Jul 2002 B1
6423036 Van Huizen Jul 2002 B1
6440061 Wenner et al. Aug 2002 B1
6440063 Beane et al. Aug 2002 B1
6443957 Addis Sep 2002 B1
6447489 Peterson Sep 2002 B1
6450983 Rambo Sep 2002 B1
6454783 Piskun Sep 2002 B1
6464686 O'Hara et al. Oct 2002 B1
6468292 Mollenauer et al. Oct 2002 B1
6482181 Racenet et al. Nov 2002 B1
6482227 Solovay Nov 2002 B1
6485435 Bakal Nov 2002 B1
6485467 Crook et al. Nov 2002 B1
6488620 Segermark et al. Dec 2002 B1
6488692 Spence et al. Dec 2002 B1
6494893 Dubrul et al. Dec 2002 B2
6527787 Fogarty et al. Mar 2003 B1
6533734 Corley, III et al. Mar 2003 B1
6551270 Bimbo et al. Apr 2003 B1
6551276 Mann et al. Apr 2003 B1
6551344 Thill Apr 2003 B2
6552109 Chen Apr 2003 B1
6554793 Pauker et al. Apr 2003 B1
6558371 Dorn May 2003 B2
6560782 Hourihan et al. May 2003 B2
6569120 Green May 2003 B1
6578577 Bonadio et al. Jun 2003 B2
6579281 Palmer et al. Jun 2003 B2
6582364 Butler et al. Jun 2003 B2
6585773 Xie Jul 2003 B1
6589167 Shimomura et al. Jul 2003 B1
6589208 Ewers Jul 2003 B2
6589211 MacLeod Jul 2003 B1
6607504 Haarala et al. Aug 2003 B2
6613952 Rambo Sep 2003 B2
6623426 Bonadio et al. Sep 2003 B2
6627275 Chen Sep 2003 B1
6663598 Carrillo et al. Dec 2003 B1
6669674 Macoviak et al. Dec 2003 B1
6676639 Ternström Jan 2004 B1
6702787 Racenet et al. Mar 2004 B2
6705989 Cuschieri et al. Mar 2004 B2
6706050 Giannadakis Mar 2004 B1
6714298 Ryer Mar 2004 B2
6716201 Blanco Apr 2004 B2
6723044 Pulford et al. Apr 2004 B2
6723088 Gaskill, III et al. Apr 2004 B2
6725080 Melkent et al. Apr 2004 B2
6793621 Butler et al. Sep 2004 B2
6794440 Chen Sep 2004 B2
6796940 Bonadio et al. Sep 2004 B2
6797765 Pearce Sep 2004 B2
6800084 Davison et al. Oct 2004 B2
6811546 Callas et al. Nov 2004 B1
6814078 Crook Nov 2004 B2
6814700 Mueller et al. Nov 2004 B1
6817974 Cooper et al. Nov 2004 B2
6830578 O'Heeron et al. Dec 2004 B2
6837893 Miller Jan 2005 B2
6840946 Fogarty et al. Jan 2005 B2
6840951 de la Torre et al. Jan 2005 B2
6846287 Bonadio et al. Jan 2005 B2
6860463 Hartley Mar 2005 B2
6863674 Kasahara et al. Mar 2005 B2
6866861 Luhman Mar 2005 B1
6867253 Chen Mar 2005 B1
6869393 Butler Mar 2005 B2
6878110 Yang et al. Apr 2005 B2
6884253 McFarlane Apr 2005 B1
6890295 Michels et al. May 2005 B2
6895965 Scarberry et al. May 2005 B2
6901870 Eklöf et al. Jun 2005 B2
6902541 McNally et al. Jun 2005 B2
6902569 Parmer et al. Jun 2005 B2
6908430 Caldwell et al. Jun 2005 B2
6909220 Chen Jun 2005 B2
6913609 Yencho et al. Jul 2005 B2
6916310 Sommerich Jul 2005 B2
6916331 Mollenauer et al. Jul 2005 B2
6929637 Gonzalez et al. Aug 2005 B2
6936005 Poff et al. Aug 2005 B2
6936037 Bubb et al. Aug 2005 B2
6939296 Ewers et al. Sep 2005 B2
6945932 Caldwell et al. Sep 2005 B1
6958037 Ewers et al. Oct 2005 B2
6958069 Shipp et al. Oct 2005 B2
6972026 Caldwell et al. Dec 2005 B1
6979324 Bybordi et al. Dec 2005 B2
6991602 Nakazawa et al. Jan 2006 B2
6997909 Goldberg Feb 2006 B2
7001397 Davison et al. Feb 2006 B2
7008377 Beane et al. Mar 2006 B2
7014628 Bousquet Mar 2006 B2
7033319 Pulford et al. Apr 2006 B2
7041056 Deslauriers et al. May 2006 B2
7052454 Taylor May 2006 B2
7056304 Bacher et al. Jun 2006 B2
7056321 Pagliuca et al. Jun 2006 B2
7067583 Chen Jun 2006 B2
7077852 Fogarty et al. Jul 2006 B2
7081089 Bonadio et al. Jul 2006 B2
7083626 Hart et al. Aug 2006 B2
7093599 Chen Aug 2006 B2
7100614 Stevens et al. Sep 2006 B2
7101353 Liu et al. Sep 2006 B2
7105009 Johnson Sep 2006 B2
7105607 Chen Sep 2006 B2
7112185 Hart et al. Sep 2006 B2
7118528 Piskun Oct 2006 B1
7134929 Chen Nov 2006 B2
7153261 Wenchell Dec 2006 B2
7163510 Kahle et al. Jan 2007 B2
7192436 Sing et al. Mar 2007 B2
7193002 Chen Mar 2007 B2
7195590 Butler et al. Mar 2007 B2
7214185 Rosney et al. May 2007 B1
7217277 Parihar et al. May 2007 B2
7222380 Chen May 2007 B2
7223257 Shubayev et al. May 2007 B2
7223278 Davison et al. May 2007 B2
7226484 Chen Jun 2007 B2
7235062 Brustad Jun 2007 B2
7235084 Skakoon et al. Jun 2007 B2
7238154 Ewers et al. Jul 2007 B2
7244244 Racenet et al. Jul 2007 B2
7276075 Callas et al. Oct 2007 B1
7290367 Chen Nov 2007 B2
7294103 Bertolero et al. Nov 2007 B2
7297106 Yamada et al. Nov 2007 B2
7300399 Bonadio et al. Nov 2007 B2
7316699 McFarlane Jan 2008 B2
7331940 Sommerich Feb 2008 B2
7338473 Campbell et al. Mar 2008 B2
7344546 Wulfman et al. Mar 2008 B2
7344547 Piskun Mar 2008 B2
7344568 Chen Mar 2008 B2
7377898 Ewers et al. May 2008 B2
7390317 Taylor et al. Jun 2008 B2
7393322 Wenchell Jul 2008 B2
7412977 Fields et al. Aug 2008 B2
7445597 Butler et al. Nov 2008 B2
7473221 Ewers et al. Jan 2009 B2
7481765 Ewers et al. Jan 2009 B2
7537564 Bonadio et al. May 2009 B2
7540839 Butler et al. Jun 2009 B2
7559893 Bonadio et al. Jul 2009 B2
7578832 Johnson Aug 2009 B2
7645232 Shluzas Jan 2010 B2
7650887 Nguyen et al. Jan 2010 B2
7661164 Chen Feb 2010 B2
7704207 Albrecht et al. Apr 2010 B2
7717847 Smith May 2010 B2
7727146 Albrecht et al. Jun 2010 B2
7727255 Taylor et al. Jun 2010 B2
7736306 Brustad et al. Jun 2010 B2
7749415 Brustad et al. Jul 2010 B2
7753901 Piskun et al. Jul 2010 B2
7758500 Boyd et al. Jul 2010 B2
7766824 Jensen et al. Aug 2010 B2
7811251 Wenchell Oct 2010 B2
7815567 Albrecht et al. Oct 2010 B2
7837612 Gill et al. Nov 2010 B2
7841765 Keller Nov 2010 B2
7850600 Piskun Dec 2010 B1
7850667 Gresham Dec 2010 B2
7867164 Butler et al. Jan 2011 B2
7878974 Brustad et al. Feb 2011 B2
7896889 Mazzocchi et al. Mar 2011 B2
7909760 Albrecht et al. Mar 2011 B2
7930782 Chen Apr 2011 B2
8029522 Ortiz Oct 2011 B2
8043329 Khairkhahan Oct 2011 B2
8157833 Au Apr 2012 B2
8262568 Albrecht Sep 2012 B2
8343047 Albrecht Jan 2013 B2
8414483 Farrell Apr 2013 B2
8480675 Betts Jul 2013 B2
8641758 Anderson et al. Feb 2014 B1
8968191 Pribanic Mar 2015 B2
9265526 Abdou Feb 2016 B1
9289115 Dang Mar 2016 B2
9289200 Dang Mar 2016 B2
9364339 Mayer Jun 2016 B2
9492197 Juravic Nov 2016 B2
9554787 McCarthy Jan 2017 B2
9585550 Abel Mar 2017 B2
9662139 Shipp May 2017 B2
9872702 Dang Jan 2018 B2
20010037053 Bonadio et al. Nov 2001 A1
20010047188 Bonadio et al. Nov 2001 A1
20020002324 McManus Jan 2002 A1
20020010389 Butler et al. Jan 2002 A1
20020013542 Bonadio et al. Jan 2002 A1
20020016607 Bonadio et al. Feb 2002 A1
20020026230 Moll et al. Feb 2002 A1
20020038077 de la Torre et al. Mar 2002 A1
20020068879 Lubock Jun 2002 A1
20020072762 Bonadio et al. Jun 2002 A1
20020111536 Cuschieri et al. Aug 2002 A1
20020156432 Racenet Oct 2002 A1
20020162559 Crook Nov 2002 A1
20030004253 Chen Jan 2003 A1
20030014076 Mollenauer et al. Jan 2003 A1
20030028179 Piskun Feb 2003 A1
20030040711 Racenet et al. Feb 2003 A1
20030059865 Nelson Mar 2003 A1
20030078476 Hill Apr 2003 A1
20030078478 Bonadio et al. Apr 2003 A1
20030139756 Brustad Jul 2003 A1
20030167040 Bacher et al. Sep 2003 A1
20030167069 Gonzales Sep 2003 A1
20030187376 Rambo Oct 2003 A1
20030191371 Smith et al. Oct 2003 A1
20030192553 Rambo Oct 2003 A1
20030225392 McMichael et al. Dec 2003 A1
20030236505 Bonadio et al. Dec 2003 A1
20030236549 Bonadio et al. Dec 2003 A1
20040015185 Ewers et al. Jan 2004 A1
20040024363 Goldberg Feb 2004 A1
20040049099 Ewers et al. Mar 2004 A1
20040049100 Butler Mar 2004 A1
20040054353 Taylor Mar 2004 A1
20040063833 Chen Apr 2004 A1
20040068232 Hart et al. Apr 2004 A1
20040070187 Chen Apr 2004 A1
20040072942 Chen Apr 2004 A1
20040073090 Butler Apr 2004 A1
20040092795 Bonadio et al. May 2004 A1
20040092796 Butler et al. May 2004 A1
20040093018 Johnson May 2004 A1
20040097793 Butler et al. May 2004 A1
20040106942 Taylor et al. Jun 2004 A1
20040111061 Curran Jun 2004 A1
20040127772 Ewers et al. Jul 2004 A1
20040138529 Wiltshire et al. Jul 2004 A1
20040143158 Hart et al. Jul 2004 A1
20040154624 Bonadio et al. Aug 2004 A1
20040167559 Taylor et al. Aug 2004 A1
20040173218 Yamada et al. Sep 2004 A1
20040215063 Bonadio et al. Oct 2004 A1
20040230161 Zeiner Nov 2004 A1
20040243144 Bonadio et al. Dec 2004 A1
20040249248 Bonadio et al. Dec 2004 A1
20040254426 Wenchell Dec 2004 A1
20040260244 Piechowicz et al. Dec 2004 A1
20040267096 Caldwell et al. Dec 2004 A1
20050020884 Hart et al. Jan 2005 A1
20050033246 Ahlbert et al. Feb 2005 A1
20050033327 Gainor et al. Feb 2005 A1
20050059865 Kahle et al. Mar 2005 A1
20050065475 Hart et al. Mar 2005 A1
20050065543 Kahle et al. Mar 2005 A1
20050080319 Dinkler, II et al. Apr 2005 A1
20050090713 Gozales et al. Apr 2005 A1
20050090716 Bonadio et al. Apr 2005 A1
20050090717 Bonadio et al. Apr 2005 A1
20050096695 Olich May 2005 A1
20050131349 Albrecht et al. Jun 2005 A1
20050148823 Vaugh et al. Jul 2005 A1
20050155611 Vaugh et al. Jul 2005 A1
20050159647 Hart et al. Jul 2005 A1
20050159650 Raymond et al. Jul 2005 A1
20050165281 Ravikumar et al. Jul 2005 A1
20050165432 Heinrich Jul 2005 A1
20050192483 Bonadio et al. Sep 2005 A1
20050192598 Johnson et al. Sep 2005 A1
20050192608 Moreno Sep 2005 A1
20050197537 Bonadio et al. Sep 2005 A1
20050203346 Bonadio et al. Sep 2005 A1
20050209510 Bonadio et al. Sep 2005 A1
20050215863 Ravikumar et al. Sep 2005 A1
20050222582 Wenchell Oct 2005 A1
20050228447 Rambo Oct 2005 A1
20050240082 Bonadio et al. Oct 2005 A1
20050241647 Nguyen Nov 2005 A1
20050251124 Zvuloni et al. Nov 2005 A1
20050261720 Caldwell et al. Nov 2005 A1
20050267419 Smith Dec 2005 A1
20050277946 Greenhalgh Dec 2005 A1
20050283050 Gundlapalli et al. Dec 2005 A1
20050288558 Ewers et al. Dec 2005 A1
20050288634 O'Heeron et al. Dec 2005 A1
20060020164 Butler et al. Jan 2006 A1
20060020241 Piskun et al. Jan 2006 A1
20060030755 Ewers et al. Feb 2006 A1
20060041270 Lenker Feb 2006 A1
20060047284 Gresham Mar 2006 A1
20060047293 Haberland et al. Mar 2006 A1
20060052669 Hart Mar 2006 A1
20060084842 Hart et al. Apr 2006 A1
20060106402 McLucas May 2006 A1
20060129165 Edoga et al. Jun 2006 A1
20060149137 Pingleton et al. Jul 2006 A1
20060149306 Hart et al. Jul 2006 A1
20060161049 Beane et al. Jul 2006 A1
20060161050 Butler et al. Jul 2006 A1
20060241651 Wilk Oct 2006 A1
20060247498 Bonadio et al. Nov 2006 A1
20060247499 Butler et al. Nov 2006 A1
20060247500 Voegele et al. Nov 2006 A1
20060247516 Hess et al. Nov 2006 A1
20060247586 Voegele et al. Nov 2006 A1
20060247673 Voegele et al. Nov 2006 A1
20060247678 Weisenburgh, II et al. Nov 2006 A1
20060258899 Gill et al. Nov 2006 A1
20060264706 Piskun Nov 2006 A1
20060270911 Voegele et al. Nov 2006 A1
20070004968 Bonadio et al. Jan 2007 A1
20070049966 Bonadio et al. Mar 2007 A1
20070088202 Albrecht et al. Apr 2007 A1
20070088204 Albrecht Apr 2007 A1
20070088258 Wenchell Apr 2007 A1
20070093695 Bonadio et al. Apr 2007 A1
20070106319 Au May 2007 A1
20070118175 Butler et al. May 2007 A1
20070142780 Van Lue Jun 2007 A1
20070149859 Albrecht Jun 2007 A1
20070151566 Kahle et al. Jul 2007 A1
20070156023 Frasier et al. Jul 2007 A1
20070156024 Frasier et al. Jul 2007 A1
20070185387 Albrecht et al. Aug 2007 A1
20070203398 Bonadio et al. Aug 2007 A1
20070208312 Norton Sep 2007 A1
20070239108 Albrecht Oct 2007 A1
20070255219 Vaugh et al. Nov 2007 A1
20070270654 Pignato Nov 2007 A1
20070270752 Labombard Nov 2007 A1
20070299387 Williams et al. Dec 2007 A1
20080027476 Piskun Jan 2008 A1
20080048011 Weller Feb 2008 A1
20080086080 Mastri Apr 2008 A1
20080097162 Bonadio et al. Apr 2008 A1
20080097163 Butler et al. Apr 2008 A1
20080103366 Banchieri et al. May 2008 A1
20080200767 Ewers et al. Aug 2008 A1
20080255519 Piskun et al. Oct 2008 A1
20080281161 Albrecht et al. Nov 2008 A1
20080281162 Albrecht et al. Nov 2008 A1
20090012477 Norton et al. Jan 2009 A1
20090036745 Bonadio et al. Feb 2009 A1
20090069627 Haindl Mar 2009 A1
20090069837 Bonadio et al. Mar 2009 A1
20090093683 Richard et al. Apr 2009 A1
20090093752 Richard et al. Apr 2009 A1
20090131754 Ewers et al. May 2009 A1
20090137879 Ewers et al. May 2009 A1
20090149714 Bonadio Jun 2009 A1
20090182279 Wenchell Jul 2009 A1
20090182282 Okihisa Jul 2009 A1
20090187079 Albrecht Jul 2009 A1
20090227843 Smith et al. Sep 2009 A1
20090292176 Bonadio et al. Nov 2009 A1
20090326330 Bonadio et al. Dec 2009 A1
20100063362 Bonadio et al. Mar 2010 A1
20100063364 Bonadio et al. Mar 2010 A1
20100063452 Edelman et al. Mar 2010 A1
20100081880 Widenhouse et al. Apr 2010 A1
20100081881 Murray et al. Apr 2010 A1
20100081995 Widenhouse et al. Apr 2010 A1
20100094227 Albrecht et al. Apr 2010 A1
20100100043 Racenet Apr 2010 A1
20100113882 Widenhouse et al. May 2010 A1
20100198156 Rosch Aug 2010 A1
20100211012 Hathaway Aug 2010 A1
20100217087 Bonadio et al. Aug 2010 A1
20100228091 Widenhouse et al. Sep 2010 A1
20100228092 Ortiz et al. Sep 2010 A1
20100228094 Ortiz et al. Sep 2010 A1
20100240960 Richard Sep 2010 A1
20100249523 Spiegel et al. Sep 2010 A1
20100249524 Ransden et al. Sep 2010 A1
20100249525 Shelton, IV et al. Sep 2010 A1
20100249526 Shelton, IV Sep 2010 A1
20100249694 Choi et al. Sep 2010 A1
20100261972 Widenhouse et al. Oct 2010 A1
20100261975 Huey et al. Oct 2010 A1
20100262080 Shelton, IV Oct 2010 A1
20100286483 Bettuchi Nov 2010 A1
20100286484 Stellon et al. Nov 2010 A1
20100298646 Stellon et al. Nov 2010 A1
20100305407 Farley Dec 2010 A1
20100312064 Weisenburgh, II Dec 2010 A1
20110021877 Fortier et al. Jan 2011 A1
20110021881 Wenchell Jan 2011 A1
20110028891 Okoniewski Feb 2011 A1
20110034935 Kleyman Feb 2011 A1
20110034946 Kleyman Feb 2011 A1
20110034947 Kleyman Feb 2011 A1
20110040324 McCarthy Feb 2011 A1
20110054260 Albrecht et al. Mar 2011 A1
20110071462 Ewers et al. Mar 2011 A1
20110071463 Ewers et al. Mar 2011 A1
20110144443 Shelton, IV et al. Jun 2011 A1
20110144590 Sakai, Jr. Jun 2011 A1
20110160820 Jackson et al. Jun 2011 A1
20120095297 Dang Apr 2012 A1
20120130191 Pribanic May 2012 A1
20120190933 Kleyman Jul 2012 A1
20120238825 Smith Sep 2012 A1
20120245425 Okoniewski Sep 2012 A1
20130053863 Juravic Feb 2013 A1
20130072759 Li et al. Mar 2013 A1
20130190573 Smith Jul 2013 A1
20130204092 Hannaford Aug 2013 A1
20130245381 Dang Sep 2013 A1
20130296655 Hart Nov 2013 A1
20130317617 Mayer Nov 2013 A1
20140142393 Piskun May 2014 A1
20140142509 Bonutti May 2014 A1
20140275801 Menchaca Sep 2014 A1
20150087913 Dang Mar 2015 A1
20150164552 Chen et al. Jun 2015 A1
20150272564 Piskun Oct 2015 A1
20160045220 Wachli Feb 2016 A1
20160151087 Dang Jun 2016 A1
20160157888 Dang Jun 2016 A1
20160166282 Juravic Jun 2016 A1
20190090904 Wachli Mar 2019 A1
Foreign Referenced Citations (153)
Number Date Country
202751416 Feb 2013 CN
26 05 148 Aug 1977 DE
33 36 279 Jan 1986 DE
37 39 532 Dec 1988 DE
37 37 121 May 1989 DE
296 00 939 Jun 1996 DE
1982809 Dec 1999 DE
0 113 520 Jul 1984 EP
0 142 262 May 1985 EP
0 517 248 Dec 1992 EP
0 537 768 Apr 1993 EP
0 807 416 Nov 1997 EP
0 849 517 Jun 1998 EP
0 950 376 Oct 1999 EP
1 118 657 Jul 2001 EP
1 125 552 Aug 2001 EP
1 312 318 May 2003 EP
1 407 715 Apr 2004 EP
1 609 429 Dec 2005 EP
1 609 429 Dec 2005 EP
2 044 889 Apr 2009 EP
2 260 777 Dec 2010 EP
2 272 450 Jan 2011 EP
2 340 792 Jul 2011 EP
2 486 882 Aug 2012 EP
2 589 443 May 2013 EP
2 609 880 Jul 2013 EP
2 617 373 Jul 2013 EP
1456623 Sep 1966 FR
1151993 May 1969 GB
1355611 Jun 1974 GB
1372491 Oct 1974 GB
1379772 Jan 1975 GB
1400808 Jul 1975 GB
1407023 Sep 1975 GB
1482857 Aug 1977 GB
1496696 Dec 1977 GB
2071502 Sep 1981 GB
2255019 Oct 1992 GB
2275420 Aug 1994 GB
2298906 Sep 1996 GB
930649 Sep 1993 IE
930650 Sep 1993 IE
S940150 Feb 1994 IE
S940613 Aug 1994 IE
S940960 Dec 1994 IE
S950055 Jan 1995 IE
S950266 Apr 1995 IE
S71634 Feb 1997 IE
S75368 Aug 1997 IE
S960196 Aug 1997 IE
S970810 Nov 1997 IE
991010 Jul 2000 IE
990218 Nov 2000 IE
990219 Nov 2000 IE
990220 Nov 2000 IE
990660 Feb 2001 IE
990795 Mar 2001 IE
10-108868 Apr 1998 JP
11-290327 Oct 1999 JP
2001-61850 Mar 2001 JP
2002-28163 Jan 2002 JP
02003 235879 Aug 2003 JP
2004-195037 Jul 2004 JP
2007-44395 Feb 2007 JP
20140074622 Jun 2014 KR
1342485 Jan 1997 RU
WO 8606272 Nov 1986 WO
WO 8606316 Nov 1986 WO
WO 9211880 Jul 1992 WO
WO 9221292 Dec 1992 WO
WO 9305740 Apr 1993 WO
WO 9314801 Aug 1993 WO
WO 9404067 Mar 1994 WO
WO 9422357 Oct 1994 WO
WO 9505207 Feb 1995 WO
WO 9507056 Mar 1995 WO
WO 9522289 Aug 1995 WO
WO 9524864 Sep 1995 WO
WO 9527445 Oct 1995 WO
WO 9527468 Oct 1995 WO
WO 9636283 Nov 1996 WO
WO 9711642 Apr 1997 WO
WO 9732514 Sep 1997 WO
WO 9732515 Sep 1997 WO
WO 9742889 Nov 1997 WO
WO 9819853 May 1998 WO
WO 9835614 Aug 1998 WO
WO 9848724 Nov 1998 WO
WO 9903416 Jan 1999 WO
WO 9915068 Apr 1999 WO
WO 9916368 Apr 1999 WO
WO 9922804 May 1999 WO
WO 9925268 May 1999 WO
WO 9929250 Jun 1999 WO
WO 0032116 Jun 2000 WO
WO 0032117 Jun 2000 WO
WO 0032119 Jun 2000 WO
WO 0032120 Jun 2000 WO
WO 0035356 Jun 2000 WO
WO 0047117 Aug 2000 WO
WO 0054675 Sep 2000 WO
WO 0054676 Sep 2000 WO
WO 0054677 Sep 2000 WO
WO 0108563 Feb 2001 WO
WO 0108581 Feb 2001 WO
WO 0126558 Apr 2001 WO
WO 0126559 Apr 2001 WO
WO 01045568 Jun 2001 WO
WO 0149363 Jul 2001 WO
WO 0191652 Dec 2001 WO
WO 0207611 Jan 2002 WO
WO 0217800 Mar 2002 WO
WO 0234108 May 2002 WO
WO 03011153 Feb 2003 WO
WO 03011551 Feb 2003 WO
WO 03026512 Apr 2003 WO
WO 03032819 Apr 2003 WO
WO 03034908 May 2003 WO
WO 03061480 Jul 2003 WO
WO 03077726 Sep 2003 WO
WO 03103548 Dec 2003 WO
WO 2004026153 Apr 2004 WO
WO 2004030547 Apr 2004 WO
WO 2004075730 Sep 2004 WO
WO 2004075741 Sep 2004 WO
WO 2004075930 Sep 2004 WO
WO 2005009257 Feb 2005 WO
WO 2005034766 Apr 2005 WO
WO 2005089661 Sep 2005 WO
WO 2006040748 Apr 2006 WO
WO 2006057982 Jun 2006 WO
WO 2006057982 Jun 2006 WO
WO 2006059318 Jun 2006 WO
WO 2006059318 Jun 2006 WO
WO 2006100658 Sep 2006 WO
WO 2007044849 Apr 2007 WO
WO 2007083305 Jul 2007 WO
WO 2007083305 Jul 2007 WO
WO 2008011358 Jan 2008 WO
WO 2008015566 Feb 2008 WO
WO 2008045935 Apr 2008 WO
WO 2008093313 Aug 2008 WO
WO 2008121294 Oct 2008 WO
WO 2009117435 Sep 2009 WO
WO-2009117435 Sep 2009 WO
WO 2010045253 Apr 2010 WO
WO 2010082722 Jul 2010 WO
WO 2010104259 Sep 2010 WO
WO 2010141673 Dec 2010 WO
WO 2012154845 Nov 2012 WO
WO 2013106569 Jul 2013 WO
WO 2014174031 Oct 2014 WO
Non-Patent Literature Citations (132)
Entry
U.S. Appl. No. 10/381,220, filed Mar. 20, 2003; Title: Surgical Access Apparatus and Method, now U.S. Pat. No. 7,473,221 issued Jan. 6, 2009.
U.S. Appl. No. 10/436,522, filed May 13, 2003; Title: Laparoscopic Illumination Apparatus and Method, now U.S. Pat. No. 6,939,296 issued Sep. 6, 2005.
U.S. Appl. No. 10/399,209, filed Aug. 22, 2003; Title: Wound Retraction Apparatus and Method, now U.S. Pat. No. 6,958,037 issued Oct. 25, 2005.
U.S. Appl. No. 11/218,412, filed Sep. 1, 2005; Title: Wound Retraction Apparatus and Method, now U.S. Pat. No. 7,238,154 issued Jul. 3, 2007.
U.S. Appl. No. 10/399,057, filed Apr. 11, 2003; Title: Sealed Surgical Access Device, now U.S. Pat. No. 7,052,454 issued May 30, 2006.
U.S. Appl. No. 10/666,579, filed Sep. 17, 2003; Title: Surgical Instrument Access Device, now U.S. Pat. No. 7,163,510 issued Jan. 16, 2007.
U.S. Appl. No. 10/052,297, filed Jan. 18, 2002; Title: Hand Access Port Device, now U.S. Pat. No. 6,908,430 issued Jun. 21, 2005.
U.S. Appl. No. 08/015,765, filed Feb. 10, 1993; Title: Gas-Tight Seal Accomodating Surgical Instruments With a Wide Range of Diameters, now U.S. Pat. No. 5,407,433 issued Apr. 18, 1995.
U.S. Appl. No. 08/040,373, filed Mar. 30, 1993; Title: Gas-Tight Seal Accomodating Surgical Instruments With a Wide Range of Diameters, now U.S. Pat. No. 5,411,483 issued May 2, 1995.
U.S. Appl. No. 10/902,756, filed Jul. 29, 2004; Title: Hand Access Port Device, now abandoned.
U.S. Appl. No. 10/802,125, filed Mar. 15, 2004; Title: Surgical Guide Valve, now abandoned.
U.S. Appl. No. 10/516,198, filed Nov. 30, 2004; Title: Wound Retractor, now U.S. Pat. No. 7,650,887 issued Jan. 26, 2010.
U.S. Appl. No. 10/927,551, filed Aug. 25, 2004; Title: Surgical Access System, now abandoned.
U.S. Appl. No. 11/244,647, filed Oct. 5, 2005; Title: Surgical Access Apparatus and Method, now U.S. Pat. No. 7,481,765 issued Jan. 27, 2009.
U.S. Appl. No. 11/548,746, filed Oct. 12, 2006; Title: Method of Making a Hand Access Laparoscopic Device, now U.S. Pat. No. 7,749,415 issued Jul. 6, 2010.
U.S. Appl. No. 11/548,765, filed Oct. 12, 2006; Title: Split Hoop Wound Retractor, now U.S. Pat. No. 7,815,567 issued Oct. 26, 2010.
U.S. Appl. No. 11/548,767, filed Oct. 12, 2006; Title: Circular Surgical Retractor now U.S. Pat. No. 7,704,207 issued Apr. 27, 2010.
U.S. Appl. No. 11/548,781, filed Oct. 12, 2006; Title: Wound Retractor With Gel Cap, now U.S. Pat. No. 7,727,146 issued Jun. 1, 2010.
U.S. Appl. No. 11/548,955, filed Oct. 12, 2006; Title: Hand Access Laparoscopic Device, now U.S. Pat. No. 7,736,306 issued Jun. 15, 2010.
U.S. Appl. No. 11/755,305, filed May 30, 2007; Title: Wound Retraction Apparatus and Method, now U.S. Pat. No. 7,377,898 issued May 27, 2008.
U.S. Appl. No. 11/548,758, filed Oct. 12, 2007; Title: Split Hoop Wound Retractor With Gel Pad, now U.S. Pat. No. 7,909,760 issued Mar. 22, 2011.
U.S. Appl. No. 12/693,242, filed Jan. 1, 2010; Title: Wound Retractor, now U.S. Pat. No. 7,913,697 issued Mar. 29, 2011.
U.S. Appl. No. 12/768,328, filed Apr. 27, 2010; Title: Circular Surgical Retractor, now U.S. Pat. No. 7,892,172 issued Feb. 22, 2011.
U.S. Appl. No. 12/791,666, filed Jun. 1, 2010; Title: Wound Retractor With Gel Cap, now U.S. Pat. No. 7,883,461 issued Feb. 8, 2011.
U.S. Appl. No. 12/815,986, filed Jun. 15, 2010; Title: Hand Access Laparoscopic Device, now U.S. Pat. No. 7,878,974 issued Feb. 1, 2011.
U.S. Appl. No. 10/695,295, filed Oct. 28, 2003; Title: Surgical Gel Seal.
U.S. Appl. No. 11/132,741, filed May 18, 2005; Title: Gas-Tight Seal Accomodating Surgical Instruments With a Wide Range of Diameters.
U.S. Appl. No. 11/245,709, filed Oct. 7, 2005; Title: Surgical Access System.
U.S. Appl. No. 11/330,661, filed Jan. 12, 2006; Title: Sealed Surgical Access Device.
U.S. Appl. No. 11/564,409, filed Nov. 29, 2006; Title: Surgical Instrument Access Device.
U.S. Appl. No. 12/108,400, filed Apr. 23, 2008; Title: Wound Retraction Apparatus and Method.
U.S. Appl. No. 12/119,371, filed May 12, 2008; Title: Surgical Retractor With Gel Pad.
U.S. Appl. No. 12/119,414, filed May 12, 2008; Title: Surgical Retractor.
U.S. Appl. No. 12/358,080, filed Jan. 22, 2009; Title: Surgical Instrument Access Device.
U.S. Appl. No. 12/360,634, filed Jan. 27, 2009; Title: Surgical Access Apparatus and Method.
U.S. Appl. No. 12/360,710, filed Jan. 27, 2009; Title: Surgical Access Apparatus and Method.
U.S. Appl. No. 12/578,422, filed Oct. 13, 2009; Title: Single Port Access System.
U.S. Appl. No. 12/905,932, filed Oct. 15, 2010; Title: Split Hoop Wound Retractor.
U.S. Appl. No. 12/960,449, filed Dec. 3, 2010; Title: Surgical Access Apparatus and Method.
U.S. Appl. No. 12/960,458, filed Dec. 3, 2010; Title: Surgical Access Apparatus and Method.
U.S. Appl. No. 13/006,727, filed Jan. 14, 2011; Title: Hand Access Laparoscopic Device.
U.S. Appl. No. 13/008,728, filed Jan. 18, 2011; Title: Wound Retractor With Gel Cap.
U.S. Appl. No. 13/023,334, filed Feb. 8, 2011; Title: Circular Surgical Retractor.
U.S. Appl. No. 13/031,892, filed Feb. 22, 2011; Title: Wound Retractor.
U.S. Appl. No. 13/050,042, filed Mar. 17, 2011; Title: Split Hoop Wound Retractor With Gel Pad.
U.S. Appl. No. 10/446,365, filed May 28, 2003; Title: Screw-Type Seal With Inflatable Membrane.
U.S. Appl. No. 12/004,439, filed Dec. 20, 2007; Title: Skin Seal.
U.S. Appl. No. 12/004,441, filed Dec. 20, 2007; Title: Screw-Type Skin Seal With Inflatable Membrane.
U.S. Appl. No. 12/607,667, filed Oct. 28, 2009; Title: Screw-Type Skin Seal With Inflatable Membrane.
U.S. Appl. No. 10/965,217, filed Oct. 15, 2004; Title: Surgical Sealing Device.
U.S. Appl. No. 10/981,730, filed Nov. 5, 2004; Title: Surgical Sealing Device.
U.S. Appl. No. 11/246,909, filed Oct. 11, 2005; Title: Instrument Access Device.
U.S. Appl. No. 11/291,089, filed Dec. 1, 2005; Title: A Surgical Sealing Device.
U.S. Appl. No. 11/486,383, filed Jul. 14, 2006; Title: Wound Retractor.
U.S. Appl. No. 11/785,752, filed Apr. 19, 2007; Title: Instrument Access Device.
U.S. Appl. No. 12/244,024, filed Oct. 2, 2008; Title: Seal Anchor for Use in Surgical Procedures.
U.S. Appl. No. 12/578,832, filed Oct. 14, 2009; Title: Flexible Access Device for Use in Surgical Procedure.
U.S. Appl. No. 12/706,043, filed Feb. 16, 2010; Title: Flexible Port Seal.
U.S. Appl. No. 12/719,341, filed Mar. 8, 2010; Title: Foam Port and Introducer Assembly.
U.S. Appl. No. 10/895,546, filed Jul. 21, 2004; Title: Laparoscopic Instrument and Cannula Assembly and Related Surgical Method.
U.S. Appl. No. 10/913,565, filed Aug. 5, 2004; Title: Surgical Device With Tack-Free Gel and Method of Manufacture.
Dexterity Protractor Instruction Manual by Dexterity Surgical, Inc., dated 1999.
European Patent Office, European Search Report for European Application No. EP 10 18 4681, entitled “Wound Retraction Apparatus and Method”, dated Nov. 22, 2010.
European Patent Office, European Search Report for European Application No. EP 10 18 4608, entitled “Wound Retraction Apparatus and Method”, dated Nov. 22, 2010.
European Patent Office, European Search Report for European Application No. EP 10 18 4648, entitled “Wound Retraction Apparatus and Method”, dated Nov. 22, 2010.
European Patent Office, European Search Report for European Application No. EP 10 18 4731, entitled “Wound Retraction Apparatus and Method”, dated Nov. 22, 2010.
European Patent Office, European Search Report for European Application No. EP 10 18 4661, entitled “Wound Retraction Apparatus and Method”, dated Nov. 22, 2010.
European Patent Office, European Search Report for European Application No. EP 10 18 4677, entitled “Wound Retraction Apparatus and Method”, dated Nov. 22, 2010.
European Patent Office, European Search Report for European Application No. EP 10 18 9325, entitled “Split Hoop Wound Retractor”, dated Dec. 14, 2010.
European Patent Office, European Search Report for European Application No. EP 10 18 9327, entitled “Split Hoop Wound Retractor”, dated Dec. 14, 2010.
European Patent Office, European Search Report for European Application No. EP 10 18 9328, entitled “Split Hoop Wound Retractor”, dated Dec. 15, 2010.
European Patent Office, European Search Report for European Application No. EP 04 00 2888, entitled “Hand Access Port Device”, dated Sep. 10, 2004.
European Patent Office, European Search Report for European Application No. EP 04 00 2889, entitled “Hand Access Port Device”, dated Sep. 13, 2004.
European Patent Office, International Search Report and The Written Opinion of the International Searching Authority for International Application No. PCT/US2006/040154, dated Jan. 30, 2007.
European Patent Office, International Search Report and The Written Opinion of the International Searching Authority for International Application No. PCT/US2006/040073, dated Jan. 26, 2007.
European Patent Office, International Search Report and The Written Opinion of the International Searching Authority for International Application No. PCT/US2006/039905, dated Jan. 17, 2007.
European Patent Office, International Search Report and The Written Opinion of the International Searching Authority for International Application No. PCT/US2006/039883, dated Jan. 31, 2007.
European Patent Office, International Search Report and The Written Opinion of the International Searching Authority for International Application No. PCT/US2006/039800, dated Apr. 16, 2007.
European Patent Office, International Search Report and The Written Opinion of the International Searching Authority for International Application No. PCT/US2006/039799, dated Mar. 27, 2007.
European Patent Office, European Search Report for European Application No. EP 08253236 dated Feb. 10, 2009.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/037213, titled “Natural Orifice Surgery System” dated Jul. 3, 2013.
Horigame, et al., Silicone Rumen Cannula with a Soft Cylindrical Part and a Hard Flange, Journal of Dairy Science, Nov. 1989, vol. 72, No. 11, pp. 3230-3232.
Horigame, et al., Technical Note: Development of Duodoenal Cannula for Sheep, Journal of Animal Science, Apr. 1992, vol. 70, Issue 4, pp. 1216-1219.
International Searching Authority/US, International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US04/05484, dated Nov. 12, 2004.
International Searching Authority/US, International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US01/29682, dated Jun. 14, 2002.
McSweeney, Cannulation of the Rumen in Cattle and Buffaloes, Australian Veterniary Journal, Aug. 1989, vol. 66, No. 8, pp. 266-268.
Neil Sheehan, Supplemental Expert Report of Neil Sheehan, Re: U.S. Pat. No. 5,741,298, United States District Court for the Central District of California, Civil Action No. SACV 03-1322 JVS, Aug. 9, 2005.
Office Action in co-pending U.S. Appl. No. 12/360,634, dated Jan. 24, 2011 in 12 pages.
Office Action in co-pending U.S. Appl. No. 12/360,710, dated Jan. 24, 2011 in 12 pages.
Technical Note: Development of Duodenal Cannula for Sheep, Faculty of Agriculture and School of Medicine Tohokju University, Sendai 981, Japan, dated 1992.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2004/028250, dated Aug. 29, 2006.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2006/039799, dated Apr. 16, 2008.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2006/039800 dated Apr. 16, 2008.
Yamazaki, et al., Diurnal Changes in the Composition of Abomasal Digesta in Fasted and Fed Sheep, The Tohoki Journal of Agricultural Research, Mar. 1987, vol. 37, No. 3-4, pp. 49-58.
Kagaya, Laparascopic cholecystecomy via two ports, using the “Twin-Port” system, J. Hepatobiliary Pancreat Surg (2001) 8:76-80, dated Feb. 20, 2001.
Declaration of John R. Brustad dated Dec. 10, 2009, submitted in U.S. Appl. No. 11/548,955, including Appendices A-D regarding product sales brochures and production drawings from 2001 and 2005.
International Search Report and Written Opinion for PCT/IE2005/000113, dated Feb. 22, 2006.
International Searching Authority-US, International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US04/25511, dated Nov. 7, 2007.
International Bureau of WIPO, International Report on Patentability for International Application No. PCT/US04/25511, dated Dec. 6, 2007.
International Search Report and Written Opinion for PCT/IE2007/000050 dated Aug. 13, 2007.
The International Searching Authority, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US08/63445, dated Sep. 29, 2008.
The International Searching Authority, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US08/063463 dated Sep. 10, 2008.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2008/063463, entitled “Surgical Retractor”, dated Nov. 17, 2009.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US08/63445, entitled “Surgical Retractor with Gel Pad”, dated Nov. 17, 2009.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2011/054266, titled “Natural Orifice Surgery System”, dated Apr. 2, 2013.
The International Bureau of WIPO, International Preliminary Report on Patentability for Application No. PCT/US2013/037213, titled “Natural Orifice Surgery System” dated Oct. 21, 2014.
International Searching Authority—European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2011/054266, dated Feb. 9, 2012.
European Patent Office, European Search Report for European Patent No. 11172709.5, dated Aug. 16, 2011.
European Patent Office, European Search Report for European Patent No. 11172706.1, dated Aug. 16, 2011.
European Patent Office, European Search Report for European Patent No. 12151288, dated Feb. 10, 2012.
European Patent Office, European Search Report for European Patent No. 08755332, dated Apr. 18, 2012.
European Patent Office, Supplementary European Search Report for European Patent Application No. 08755322, dated Apr. 18, 2012.
European Patent Office, Supplementary European Search Report for European Patent Application No. 08755336, dated Jun. 15, 2012.
Harold W. Harrower, M.D., Isolation of Incisions into Body Cavities, The American Journal of Surgery, vol. 116, pp. 824-826, Dec. 1968.
International Searching Authority—European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2012/60997, dated Mar. 7, 2013.
International Searching Authority—European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2015/045201, dated Sep. 25, 2015.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2012/037111, “Wound Retractor,” dated Aug. 30, 2012, 21 pgs.
European Patent Office, European Search Report for European Application No. 15173370.6, titled “Wound Retractor,” dated Aug. 7, 2015, 3 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2012/037111, titled “Wound Retractor” dated Nov. 12, 2013, 15 pgs.
The International Searching Authority, International Search Report and Written Opinion of the International Searching Authority for PCT application No. PCT/US01/29682, titled “Surgical Access Apparatus and Method,” dated Jun. 14, 2002, 8 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2015/045058, titled “Wound Retractor,” dated Nov. 12, 2015, 16 pgs.
The International Searching Authority, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2015/062326, titled “Circumferential Wound Retraction with Support and Guidance Structures,” dated Jun. 21, 2016, 22 pgs.
European Patent Office, European Search Report for European Patent No. 16167739.8, titled “Wound Retractor,” dated Aug. 10, 2016, 4 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2015/045058, dated Feb. 23, 2017, 12 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2015/045201, titled “Natural Orifice Surgery System”, dated Mar. 2, 2017, 9 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/049079, titled “Wound Retractors with Non-Circular, Non-Coplanar or Non-Parallel Inner Rings,” dated Apr. 5, 2017, 21 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2015/062326, titled “Circumferential Wound Retraction with Support and Guidance Structures,” dated Jun. 8, 2017, 16 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/056109, titled “Wound Retractor with Multi-Segment Outer Ring,” dated Jul. 10, 2017, 36 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/049079, titled “Wound Retractors with Non-Circular, Non-Coplanar or Non-Parallel Inner Rings,” dated Mar. 8, 2018, 12 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/056109, titled “Wound Retractor with Multi-Segment Outer Ring,” dated Apr. 19, 2018, 11 pgs.
European Patent Office, European Search Report for European Application No. EP 10207981.4, entitled “Wound Retractor,” dated Jan. 2, 2019, 13 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 19152405.7, titled “Natural Orifice Surgery System,” dated May 6, 2019, 7 pgs.
Related Publications (1)
Number Date Country
20190090904 A1 Mar 2019 US
Provisional Applications (1)
Number Date Country
62038082 Aug 2014 US
Continuations (1)
Number Date Country
Parent 14826336 Aug 2015 US
Child 16204902 US